The data was analyzed on 2026-02-16.
Please visit https://forum.sickandabandoned.com/t/has-anybody-tried-heres-how-you-can-get-answers-to-that-question-fast/228
It is highly recommended that you start there.
The rankings section should give a rough idea as to which treatments stand out as being promising treatments.
The section ranks all of the treatments (while ignoring those with very few data points). Then, specific types of treatments such as diet will be ranked against each another (while including treatments with very few data points). That analysis should help you understand:
The charts section provides breakdowns for individual treatments. If a treatment has very few data points, it may be grouped together with other similar treatments.
The Symptoms versus treatment responses section analyzes whether self-reported symptoms correlate with treatment response.
The Severity analysis section looks at whether or not treatment responses are different based on peak severity (during the worst month of illness), current severity (past 30 days), and recovery (current versus peak severity).
If you're interested in a particular treatment, search this webpage for the name of that treatment. On desktop, use Crtl+F to bring up your browser's search function.
Treatment names are usually chosen to be short and memorable:
There is a section where multiple names for a single treatment are listed- searching for any of the names will help you find the shortened memorable names. Remember to search for brand names and shortened versions of a treatment's name.
All treatments are judged based on its average score. If all surveyees were to report mild improvement, then the average score would be 1.
For risk scoring, only the negative scores are considered. The maximum possible range is from 0 to -3.
NOTE: This way of surveying patients likely measures patient satisfaction more than medical outcomes. It also measures aspects unrelated to medical outcomes (or patient satisfaction) such as how surveyees interpret survey questions, unfilled survey questions (even though the surveyee tried that treatment), etc.
Ranking of treatments surveyed.
While the chart above is limited to the most popular treatments, the tables below have data on all 235 treatments. Some of them are grouped together based on the treatments being similar to each other.
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Avacen] | 3.00 | 0.00 | 1 |
| 2 | [Stem cells] | 1.67 | 0.00 | 12 |
| 3 | [Other diet] | 1.54 | -0.06 | 95 |
| 4 | [Urotherapy] | 1.50 | 0.00 | 4 |
| 5 | [Other brain retraining] | 1.50 | -0.01 | 173 |
| 6 | [Rupatadine] | 1.40 | 0.00 | 10 |
| 7 | [Pacing strategies] | 1.40 | -0.04 | 734 |
| 8 | [Favipiravir] | 1.33 | 0.00 | 3 |
| 9 | [Low histamine diet] | 1.29 | -0.00 | 516 |
| 10 | [Doxylamine] | 1.24 | 0.00 | 21 |
| 11 | [Anti inflammatory diet] | 1.22 | -0.02 | 209 |
| 12 | [Glutenfree diet] | 1.21 | -0.01 | 492 |
| 13 | [Prayer] | 1.20 | -0.02 | 368 |
| 14 | [ASEA Redox] | 1.18 | -0.27 | 11 |
| 15 | [Paleo diet] | 1.18 | -0.01 | 77 |
| 16 | [Photobiomodulation] | 1.17 | -0.08 | 24 |
| 17 | [Carnivore diet] | 1.16 | -0.11 | 94 |
| 18 | [Chlorine dioxide] | 1.09 | 0.00 | 23 |
| 19 | [AIP diet] | 1.06 | -0.13 | 70 |
| 20 | [Benzodiazepines] | 1.06 | -0.17 | 303 |
| 21 | [Meditation] | 1.05 | -0.02 | 708 |
| 22 | [Ayurveda] | 1.03 | -0.03 | 32 |
| 23 | [Water and salt] | 1.02 | -0.02 | 723 |
| 24 | [Quifenadine] | 1.00 | 0.00 | 1 |
| 25 | [Wahls protocol] | 1.00 | -0.16 | 19 |
| 26 | [Seldane] | 1.00 | 0.00 | 1 |
| 27 | [Other antihistamines] | 1.00 | -0.03 | 69 |
| 28 | [PLEX] | 1.00 | -0.20 | 5 |
| 29 | [HBOT <=1.5 ATA, HBOT >1.5 ATA] | 0.99 | -0.14 | 140 |
| 30 | [Avoiding exercise] | 0.97 | -0.15 | 853 |
| 31 | [Opiates] | 0.96 | -0.20 | 127 |
| 32 | [EBOO] | 0.94 | 0.00 | 17 |
| 33 | [Diazepam] | 0.93 | -0.24 | 138 |
| 34 | [Maraviroc] | 0.92 | 0.00 | 26 |
| 35 | [Ivermectin] | 0.91 | -0.14 | 245 |
| 36 | [Cardio Miracle] | 0.90 | 0.00 | 10 |
| 37 | [Time] | 0.90 | -0.30 | 1172 |
| 38 | [Monoclonals] | 0.88 | -0.12 | 25 |
| 39 | [Rapamycin] | 0.88 | 0.00 | 8 |
| 40 | [Drinking water] | 0.87 | -0.00 | 411 |
| 41 | [Other chelation] | 0.85 | -0.09 | 33 |
| 42 | [VNS] | 0.85 | -0.07 | 332 |
| 43 | [Osteopathy] | 0.82 | -0.20 | 105 |
| 44 | [Wim Hof with cold] | 0.80 | -0.16 | 185 |
| 45 | [Keto diet] | 0.80 | -0.25 | 151 |
| 46 | [Heparin, Eliquis, Clopidogrel, Xarelto, Sulod... | 0.77 | -0.22 | 168 |
| 47 | [Ambien] | 0.76 | -0.24 | 75 |
| 48 | [Colchicine] | 0.76 | -0.15 | 54 |
| 49 | [Magnesium] | 0.75 | -0.06 | 935 |
| 50 | [Root wellness] | 0.75 | -0.08 | 12 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 51 | [Multiday wet fasting] | 0.74 | -0.35 | 113 |
| 52 | [EMDR] | 0.74 | -0.15 | 145 |
| 53 | [Other muscle relaxers] | 0.73 | -0.20 | 128 |
| 54 | [Compression garments] | 0.73 | -0.05 | 438 |
| 55 | [Guanfacine] | 0.73 | -0.36 | 56 |
| 56 | [Psychedelic mushrooms] | 0.73 | -0.22 | 112 |
| 57 | [Clarinex] | 0.70 | -0.28 | 47 |
| 58 | [Mestinon] | 0.70 | -0.20 | 54 |
| 59 | [LDN] | 0.69 | -0.33 | 357 |
| 60 | [Beta blockers] | 0.69 | -0.34 | 369 |
| 61 | [Other pain relievers] | 0.67 | -0.25 | 106 |
| 62 | [Other TCM] | 0.67 | -0.20 | 99 |
| 63 | [HCG] | 0.67 | 0.00 | 3 |
| 64 | [Zyrtec] | 0.65 | -0.11 | 446 |
| 65 | [Serrapeptase] | 0.65 | -0.08 | 249 |
| 66 | [Gupta program] | 0.65 | -0.07 | 57 |
| 67 | [Cromolyn] | 0.64 | -0.29 | 56 |
| 68 | [Lumbrokinase] | 0.64 | -0.03 | 106 |
| 69 | [Patches] | 0.63 | -0.28 | 159 |
| 70 | [Intermittent fasting] | 0.62 | -0.14 | 518 |
| 71 | [Hydroxyzine] | 0.62 | -0.28 | 119 |
| 72 | [Wet cupping] | 0.62 | -0.15 | 13 |
| 73 | [IV vitamins] | 0.62 | -0.07 | 149 |
| 74 | [Red light therapy] | 0.62 | -0.06 | 207 |
| 75 | [Alinia] | 0.62 | -0.38 | 8 |
| 76 | [NIBS] | 0.61 | -0.16 | 31 |
| 77 | [Dry cupping] | 0.61 | -0.06 | 109 |
| 78 | [HELP apheresis] | 0.60 | -0.47 | 15 |
| 79 | [Acupuncture] | 0.60 | -0.18 | 401 |
| 80 | [Probiotics prebiotics] | 0.59 | -0.10 | 682 |
| 81 | [Tollovid] | 0.59 | -0.09 | 22 |
| 82 | [Quantum healing] | 0.59 | -0.11 | 27 |
| 83 | [Methylene blue] | 0.58 | -0.14 | 64 |
| 84 | [Nattokinase] | 0.58 | -0.14 | 505 |
| 85 | [Pepcid] | 0.58 | -0.20 | 397 |
| 86 | [DAO] | 0.57 | -0.13 | 132 |
| 87 | [Allegra] | 0.57 | -0.10 | 218 |
| 88 | [TRT] | 0.57 | -0.18 | 56 |
| 89 | [Kangen water] | 0.56 | 0.00 | 9 |
| 90 | [EDTA] | 0.56 | -0.22 | 18 |
| 91 | [Claritin] | 0.55 | -0.12 | 356 |
| 92 | [Plant based diet, Vegan diet] | 0.55 | -0.21 | 386 |
| 93 | [Oil of oregano] | 0.54 | -0.09 | 139 |
| 94 | [Plaquenil] | 0.54 | -0.31 | 83 |
| 95 | [DNRS] | 0.53 | -0.11 | 36 |
| 96 | [Sleeping with head of bed elevated] | 0.53 | -0.08 | 336 |
| 97 | [IV vitamin C] | 0.53 | -0.06 | 93 |
| 98 | [IV ozone] | 0.53 | -0.15 | 53 |
| 99 | [CBT] | 0.53 | -0.13 | 405 |
| 100 | [Paxlovid] | 0.53 | -0.23 | 123 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 101 | [NAC] | 0.52 | -0.10 | 551 |
| 102 | [Quercetin] | 0.52 | -0.06 | 570 |
| 103 | [B vitamins] | 0.51 | -0.07 | 911 |
| 104 | [Nigella sativa oil] | 0.50 | -0.06 | 126 |
| 105 | [Mizolastine] | 0.50 | 0.00 | 2 |
| 106 | [Melatonin] | 0.50 | -0.17 | 602 |
| 107 | [Chiropractic] | 0.50 | -0.23 | 212 |
| 108 | [TWC detox] | 0.50 | -0.10 | 20 |
| 109 | [Statins, Red yeast rice] | 0.50 | -0.14 | 139 |
| 110 | [SGB] | 0.50 | -0.12 | 34 |
| 111 | [Vitamin D] | 0.49 | -0.04 | 1009 |
| 112 | [Activated charcoal] | 0.49 | -0.09 | 107 |
| 113 | [IVIG, SCIG] | 0.48 | -0.24 | 29 |
| 114 | [Corticosteroids] | 0.48 | -0.46 | 328 |
| 115 | [Nigella sativa capsules] | 0.47 | -0.02 | 111 |
| 116 | [Curcumin] | 0.46 | -0.05 | 666 |
| 117 | [Glutathione] | 0.46 | -0.09 | 315 |
| 118 | [Dandelion] | 0.46 | -0.06 | 211 |
| 119 | [Zeolite] | 0.45 | -0.07 | 82 |
| 120 | [ALA] | 0.45 | -0.06 | 278 |
| 121 | [Ketotifen] | 0.45 | -0.42 | 62 |
| 122 | [Inuspheresis] | 0.44 | -0.33 | 9 |
| 123 | [Cat's claw] | 0.44 | -0.06 | 72 |
| 124 | [Molnupiravir] | 0.44 | 0.00 | 9 |
| 125 | [24-48 hour fasting] | 0.44 | -0.46 | 208 |
| 126 | [Resveratrol] | 0.44 | -0.04 | 266 |
| 127 | [CoQ10] | 0.43 | -0.05 | 608 |
| 128 | [Homeopathy] | 0.43 | -0.18 | 145 |
| 129 | [Aciclovir, Famciclovir, Valtrex, Valcyte] | 0.43 | -0.19 | 172 |
| 130 | [Infrared sauna] | 0.43 | -0.25 | 169 |
| 131 | [OMAD] | 0.43 | -0.32 | 276 |
| 132 | [Zinc] | 0.43 | -0.03 | 660 |
| 133 | [Fish oil etc.] | 0.43 | -0.03 | 658 |
| 134 | [Bentonite clay] | 0.42 | -0.08 | 66 |
| 135 | [Vitamin C] | 0.42 | -0.04 | 805 |
| 136 | [Lavender] | 0.42 | -0.04 | 106 |
| 137 | [St. John's Wort] | 0.41 | -0.23 | 61 |
| 138 | [Amphotericin, Canesten, Econazole, Fluconazol... | 0.41 | -0.26 | 199 |
| 139 | [Acrivastine] | 0.40 | -0.16 | 129 |
| 140 | [Nigella sativa seed] | 0.40 | -0.04 | 25 |
| 141 | [NADH] | 0.40 | -0.12 | 230 |
| 142 | [Aspirin] | 0.39 | -0.10 | 545 |
| 143 | [CBD without THC] | 0.39 | -0.15 | 346 |
| 144 | [CBD with THC] | 0.39 | -0.40 | 348 |
| 145 | [Other nicotine] | 0.38 | -0.22 | 82 |
| 146 | [Lion's mane] | 0.36 | -0.13 | 241 |
| 147 | [Augmented NAC] | 0.36 | -0.13 | 188 |
| 148 | [Advil] | 0.36 | -0.13 | 639 |
| 149 | [K vitamins] | 0.36 | -0.06 | 341 |
| 150 | [Benadryl] | 0.35 | -0.20 | 246 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 151 | [Other NSAID] | 0.35 | -0.20 | 377 |
| 152 | [Pine needle tea] | 0.33 | -0.08 | 101 |
| 153 | [Bilastine] | 0.33 | -0.20 | 15 |
| 154 | [Tylenol] | 0.31 | -0.06 | 560 |
| 155 | [Multivitamin] | 0.31 | -0.06 | 567 |
| 156 | [Montelukast] | 0.31 | -0.28 | 109 |
| 157 | [Vedicinals9] | 0.29 | -0.33 | 21 |
| 158 | [Ashwagandha] | 0.29 | -0.19 | 356 |
| 159 | [Biocidin] | 0.29 | -0.21 | 24 |
| 160 | [Abilify] | 0.29 | -0.50 | 52 |
| 161 | [Xyzal] | 0.28 | -0.41 | 68 |
| 162 | [Monolaurin] | 0.24 | -0.12 | 72 |
| 163 | [Traditional sauna] | 0.23 | -0.43 | 118 |
| 164 | [Wim Hof without cold] | 0.21 | -0.32 | 104 |
| 165 | [Multiday juice fasting] | 0.20 | -0.55 | 60 |
| 166 | [Rife] | 0.17 | -0.62 | 24 |
| 167 | [Metformin] | 0.13 | -0.30 | 77 |
| 168 | [Gabapentin] | 0.06 | -0.53 | 234 |
| 169 | [Cigarettes] | 0.05 | -0.28 | 80 |
| 170 | [Spermidine] | 0.05 | -0.10 | 62 |
| 171 | [Antiseizure] | 0.05 | -0.49 | 93 |
| 172 | [Vaping] | 0.04 | -0.30 | 97 |
| 173 | [Tetracyclines, Fluoroquinolones, Penicillins,... | 0.02 | -0.54 | 524 |
| 174 | [Semprex D] | 0.00 | -0.75 | 4 |
| 175 | [Ebastine] | 0.00 | -0.43 | 7 |
| 176 | [Astemizole] | 0.00 | 0.00 | 1 |
| 177 | [Multiday dry fasting] | -0.03 | -0.92 | 39 |
| 178 | [Frequency wand] | -0.09 | -0.91 | 11 |
| 179 | [Methotextrate, Biologic, DMARD] | -0.19 | -0.72 | 43 |
| 180 | [Lightning process] | -0.23 | -0.77 | 13 |
| 181 | [Elavil, Doxepin, Pamelor, Clomipramine, Clomi... | -0.24 | -0.63 | 216 |
| 182 | [DTPA] | -0.25 | -0.25 | 4 |
| 183 | [Remeron, Seroquel, Wellbutrin] | -0.25 | -0.68 | 316 |
| 184 | [Celexa, Lexapro, Fluvoxamine, Prozac, Paxil, ... | -0.30 | -0.74 | 553 |
| 185 | [Cymbalta, Effexor] | -0.39 | -0.85 | 175 |
| 186 | [Light exercise] | -0.52 | -0.98 | 848 |
| 187 | [Graded exercise therapy] | -0.69 | -1.18 | 335 |
| 188 | [Immunoadsorption] | -0.71 | -0.86 | 7 |
| 189 | [Intense exercise] | -2.04 | -2.24 | 647 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Pacing strategies] | 1.40 | -0.04 | 734 |
| 2 | [Avoiding exercise] | 0.97 | -0.15 | 853 |
| 3 | [Light exercise] | -0.52 | -0.98 | 848 |
| 4 | [Graded exercise therapy] | -0.69 | -1.18 | 335 |
| 5 | [Intense exercise] | -2.04 | -2.24 | 647 |
Please note that the sample sizes for certain treatments are very small. As well, the data may be highly biased and may not be representative of how other people might respond to blood thinning drugs.
Tylenol (acetaminophen) is not considered to be a blood-thinning drug. It is included because it is a common alternative to other drugs on this list (Advil, Aspirin, etc.).
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Heparin] | 1.00 | -0.18 | 34 |
| 2 | [Clopidogrel] | 0.93 | -0.19 | 59 |
| 3 | [Xarelto] | 0.92 | -0.31 | 13 |
| 4 | [Serrapeptase] | 0.65 | -0.08 | 249 |
| 5 | [Lumbrokinase] | 0.64 | -0.03 | 106 |
| 6 | [HELP apheresis] | 0.60 | -0.47 | 15 |
| 7 | [Nattokinase] | 0.58 | -0.14 | 505 |
| 8 | [Eliquis] | 0.50 | -0.29 | 56 |
| 9 | [Aspirin] | 0.39 | -0.10 | 545 |
| 10 | [Advil] | 0.36 | -0.13 | 639 |
| 11 | [Other NSAID] | 0.35 | -0.20 | 377 |
| 12 | [Tylenol] | 0.31 | -0.06 | 560 |
| 13 | [Sulodexide] | 0.00 | 0.00 | 6 |
Pacing strategies and HBOT (high ATA) are included as reference points.
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Pacing strategies] | 1.40 | -0.04 | 734 |
| 2 | [Low histamine diet] | 1.29 | -0.00 | 516 |
| 3 | [HBOT >1.5 ATA] | 1.25 | -0.12 | 69 |
| 4 | [Benzodiazepines] | 1.06 | -0.17 | 303 |
| 5 | [Heparin] | 1.00 | -0.18 | 34 |
| 6 | [PLEX] | 1.00 | -0.20 | 5 |
| 7 | [Clopidogrel] | 0.93 | -0.19 | 59 |
| 8 | [Xarelto] | 0.92 | -0.31 | 13 |
| 9 | [Maraviroc] | 0.92 | 0.00 | 26 |
| 10 | [HBOT <=1.5 ATA] | 0.75 | -0.15 | 71 |
| 11 | [Multiday wet fasting] | 0.74 | -0.35 | 113 |
| 12 | [Serrapeptase] | 0.65 | -0.08 | 249 |
| 13 | [Zyrtec] | 0.65 | -0.11 | 446 |
| 14 | [Lumbrokinase] | 0.64 | -0.03 | 106 |
| 15 | [Intermittent fasting] | 0.62 | -0.14 | 518 |
| 16 | [HELP apheresis] | 0.60 | -0.47 | 15 |
| 17 | [Pepcid] | 0.58 | -0.20 | 397 |
| 18 | [Nattokinase] | 0.58 | -0.14 | 505 |
| 19 | [Quercetin] | 0.52 | -0.06 | 570 |
| 20 | [IVIG] | 0.52 | -0.17 | 23 |
| 21 | [Statins, Red yeast rice] | 0.50 | -0.14 | 139 |
| 22 | [Eliquis] | 0.50 | -0.29 | 56 |
| 23 | [Corticosteroids] | 0.48 | -0.46 | 328 |
| 24 | [24-48 hour fasting] | 0.44 | -0.46 | 208 |
| 25 | [OMAD] | 0.43 | -0.32 | 276 |
| 26 | [Aspirin] | 0.39 | -0.10 | 545 |
| 27 | [Advil] | 0.36 | -0.13 | 639 |
| 28 | [Other NSAID] | 0.35 | -0.20 | 377 |
| 29 | [Sulodexide] | 0.00 | 0.00 | 6 |
| 30 | [Multiday dry fasting] | -0.03 | -0.92 | 39 |
Excludes anti-depressants, anti-microbials, etc.
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Opiates] | 0.96 | -0.20 | 127 |
| 2 | [Diazepam] | 0.93 | -0.24 | 138 |
| 3 | [Maraviroc] | 0.92 | 0.00 | 26 |
| 4 | [Colchicine] | 0.76 | -0.15 | 54 |
| 5 | [Other muscle relaxers] | 0.73 | -0.20 | 128 |
| 6 | [Beta blockers] | 0.69 | -0.34 | 369 |
| 7 | [Other pain relievers] | 0.67 | -0.25 | 106 |
| 8 | [Statins, Red yeast rice] | 0.50 | -0.14 | 139 |
| 9 | [Abilify] | 0.29 | -0.50 | 52 |
| 10 | [Gabapentin] | 0.06 | -0.53 | 234 |
| 11 | [Antiseizure] | 0.05 | -0.49 | 93 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Elavil, Doxepin, Pamelor, Clomipramine] | -0.23 | -0.63 | 209 |
| 2 | [Remeron, Seroquel, Wellbutrin] | -0.25 | -0.68 | 316 |
| 3 | [Celexa, Lexapro, Fluvoxamine, Prozac, Paxil, ... | -0.30 | -0.74 | 553 |
| 4 | [Cymbalta, Effexor] | -0.39 | -0.85 | 175 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Diazepam] | 0.93 | -0.24 | 138 |
| 2 | [Guanfacine] | 0.73 | -0.36 | 56 |
| 3 | [Abilify] | 0.29 | -0.50 | 52 |
| 4 | [Doxepin] | 0.26 | -0.18 | 66 |
| 5 | [Gabapentin] | 0.06 | -0.53 | 234 |
| 6 | [Antiseizure] | 0.05 | -0.49 | 93 |
| 7 | [Lexapro] | -0.04 | -0.58 | 158 |
| 8 | [Wellbutrin] | -0.07 | -0.55 | 138 |
| 9 | [Fluvoxamine] | -0.22 | -0.66 | 58 |
| 10 | [Prozac] | -0.23 | -0.80 | 93 |
| 11 | [Vortioxetine] | -0.24 | -0.71 | 21 |
| 12 | [Paxil] | -0.29 | -0.58 | 24 |
| 13 | [Cymbalta] | -0.33 | -0.79 | 100 |
| 14 | [Elavil] | -0.33 | -0.76 | 94 |
| 15 | [Seroquel] | -0.37 | -0.69 | 102 |
| 16 | [Remeron] | -0.41 | -0.89 | 76 |
| 17 | [Celexa] | -0.42 | -0.69 | 62 |
| 18 | [Clomipramine] | -0.43 | -0.57 | 7 |
| 19 | [Effexor] | -0.48 | -0.93 | 75 |
| 20 | [Zoloft] | -0.64 | -0.99 | 137 |
| 21 | [Pamelor] | -0.74 | -1.07 | 42 |
While Quetiapine / Seroquel is often thought of as a TCA, it is also a H1 receptor antagonist. It is a dopamine, serotonin, and adrenergic antagonist, and a potent antihistamine with some anticholinergic properties.
DAO = Diamine Oxidase enzyme
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Rupatadine] | 1.40 | 0.00 | 10 |
| 2 | [Doxylamine] | 1.24 | 0.00 | 21 |
| 3 | [Other antihistamines] | 1.00 | -0.03 | 69 |
| 4 | [Seldane] | 1.00 | 0.00 | 1 |
| 5 | [Quifenadine] | 1.00 | 0.00 | 1 |
| 6 | [Clarinex] | 0.70 | -0.28 | 47 |
| 7 | [Zyrtec] | 0.65 | -0.11 | 446 |
| 8 | [Hydroxyzine] | 0.62 | -0.28 | 119 |
| 9 | [Pepcid] | 0.58 | -0.20 | 397 |
| 10 | [DAO] | 0.57 | -0.13 | 132 |
| 11 | [Allegra] | 0.57 | -0.10 | 218 |
| 12 | [Claritin] | 0.55 | -0.12 | 356 |
| 13 | [Mizolastine] | 0.50 | 0.00 | 2 |
| 14 | [Ketotifen] | 0.45 | -0.42 | 62 |
| 15 | [Acrivastine] | 0.40 | -0.16 | 129 |
| 16 | [Benadryl] | 0.35 | -0.20 | 246 |
| 17 | [Bilastine] | 0.33 | -0.20 | 15 |
| 18 | [Xyzal] | 0.28 | -0.41 | 68 |
| 19 | [Doxepin] | 0.26 | -0.18 | 66 |
| 20 | [Ebastine] | 0.00 | -0.43 | 7 |
| 21 | [Astemizole] | 0.00 | 0.00 | 1 |
| 22 | [Semprex D] | 0.00 | -0.75 | 4 |
| 23 | [Seroquel] | -0.37 | -0.69 | 102 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Low histamine diet] | 1.29 | -0.00 | 516 |
| 2 | [Benzodiazepines] | 1.06 | -0.17 | 303 |
| 3 | [Diazepam] | 0.93 | -0.24 | 138 |
| 4 | [Ambien] | 0.76 | -0.24 | 75 |
| 5 | [Mestinon] | 0.70 | -0.20 | 54 |
| 6 | [LDN] | 0.69 | -0.33 | 357 |
| 7 | [Cromolyn] | 0.64 | -0.29 | 56 |
| 8 | [Montelukast] | 0.31 | -0.28 | 109 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Cardio Miracle] | 0.90 | 0.00 | 10 |
| 2 | [Magnesium] | 0.75 | -0.06 | 935 |
| 3 | [Root wellness] | 0.75 | -0.08 | 12 |
| 4 | [Probiotics prebiotics] | 0.59 | -0.10 | 682 |
| 5 | [Oil of oregano] | 0.54 | -0.09 | 139 |
| 6 | [NAC] | 0.52 | -0.10 | 551 |
| 7 | [Quercetin] | 0.52 | -0.06 | 570 |
| 8 | [B vitamins] | 0.51 | -0.07 | 911 |
| 9 | [Nigella sativa oil] | 0.50 | -0.06 | 126 |
| 10 | [TWC detox] | 0.50 | -0.10 | 20 |
| 11 | [Melatonin] | 0.50 | -0.17 | 602 |
| 12 | [Vitamin D] | 0.49 | -0.04 | 1009 |
| 13 | [Nigella sativa capsules] | 0.47 | -0.02 | 111 |
| 14 | [Glutathione] | 0.46 | -0.09 | 315 |
| 15 | [Dandelion] | 0.46 | -0.06 | 211 |
| 16 | [Curcumin] | 0.46 | -0.05 | 666 |
| 17 | [ALA] | 0.45 | -0.06 | 278 |
| 18 | [Resveratrol] | 0.44 | -0.04 | 266 |
| 19 | [Cat's claw] | 0.44 | -0.06 | 72 |
| 20 | [Fish oil etc.] | 0.43 | -0.03 | 658 |
| 21 | [Zinc] | 0.43 | -0.03 | 660 |
| 22 | [CoQ10] | 0.43 | -0.05 | 608 |
| 23 | [Vitamin C] | 0.42 | -0.04 | 805 |
| 24 | [Lavender] | 0.42 | -0.04 | 106 |
| 25 | [St. John's Wort] | 0.41 | -0.23 | 61 |
| 26 | [Nigella sativa seed] | 0.40 | -0.04 | 25 |
| 27 | [NADH] | 0.40 | -0.12 | 230 |
| 28 | [CBD without THC] | 0.39 | -0.15 | 346 |
| 29 | [CBD with THC] | 0.39 | -0.40 | 348 |
| 30 | [Augmented NAC] | 0.36 | -0.13 | 188 |
| 31 | [Lion's mane] | 0.36 | -0.13 | 241 |
| 32 | [K vitamins] | 0.36 | -0.06 | 341 |
| 33 | [Pine needle tea] | 0.33 | -0.08 | 101 |
| 34 | [Multivitamin] | 0.31 | -0.06 | 567 |
| 35 | [Monolaurin] | 0.24 | -0.12 | 72 |
| 36 | [Spermidine] | 0.05 | -0.10 | 62 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Other diet] | 1.54 | -0.06 | 95 |
| 2 | [Low histamine diet] | 1.29 | -0.00 | 516 |
| 3 | [Anti inflammatory diet] | 1.22 | -0.02 | 209 |
| 4 | [Glutenfree diet] | 1.21 | -0.01 | 492 |
| 5 | [Paleo diet] | 1.18 | -0.01 | 77 |
| 6 | [Carnivore diet] | 1.16 | -0.11 | 94 |
| 7 | [AIP diet] | 1.06 | -0.13 | 70 |
| 8 | [Wahls protocol] | 1.00 | -0.16 | 19 |
| 9 | [Keto diet] | 0.80 | -0.25 | 151 |
| 10 | [Plant based diet] | 0.65 | -0.14 | 257 |
| 11 | [Vegan diet] | 0.33 | -0.35 | 129 |
Hydroxychloroquine/Plaquenil inhibits autophagy rather than promoting it.
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Multiday wet fasting] | 0.74 | -0.35 | 113 |
| 2 | [Intermittent fasting] | 0.62 | -0.14 | 518 |
| 3 | [Plaquenil] | 0.54 | -0.31 | 83 |
| 4 | [24-48 hour fasting] | 0.44 | -0.46 | 208 |
| 5 | [Resveratrol] | 0.44 | -0.04 | 266 |
| 6 | [OMAD] | 0.43 | -0.32 | 276 |
| 7 | [Multiday juice fasting] | 0.20 | -0.55 | 60 |
| 8 | [Spermidine] | 0.05 | -0.10 | 62 |
| 9 | [Multiday dry fasting] | -0.03 | -0.92 | 39 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Avacen] | 3.00 | 0.00 | 1 |
| 2 | [Other brain retraining] | 1.50 | -0.01 | 173 |
| 3 | [Urotherapy] | 1.50 | 0.00 | 4 |
| 4 | [Prayer] | 1.20 | -0.02 | 368 |
| 5 | [ASEA Redox] | 1.18 | -0.27 | 11 |
| 6 | [Photobiomodulation] | 1.17 | -0.08 | 24 |
| 7 | [Chlorine dioxide] | 1.09 | 0.00 | 23 |
| 8 | [Meditation] | 1.05 | -0.02 | 708 |
| 9 | [Ayurveda] | 1.03 | -0.03 | 32 |
| 10 | [VNS] | 0.85 | -0.07 | 332 |
| 11 | [Osteopathy] | 0.82 | -0.20 | 105 |
| 12 | [Wim Hof with cold] | 0.80 | -0.16 | 185 |
| 13 | [EMDR] | 0.74 | -0.15 | 145 |
| 14 | [Other TCM] | 0.67 | -0.20 | 99 |
| 15 | [Gupta program] | 0.65 | -0.07 | 57 |
| 16 | [Red light therapy] | 0.62 | -0.06 | 207 |
| 17 | [Wet cupping] | 0.62 | -0.15 | 13 |
| 18 | [NIBS] | 0.61 | -0.16 | 31 |
| 19 | [Dry cupping] | 0.61 | -0.06 | 109 |
| 20 | [Acupuncture] | 0.60 | -0.18 | 401 |
| 21 | [Quantum healing] | 0.59 | -0.11 | 27 |
| 22 | [Kangen water] | 0.56 | 0.00 | 9 |
| 23 | [DNRS] | 0.53 | -0.11 | 36 |
| 24 | [CBT] | 0.53 | -0.13 | 405 |
| 25 | [Chiropractic] | 0.50 | -0.23 | 212 |
| 26 | [Zeolite] | 0.45 | -0.07 | 82 |
| 27 | [Homeopathy] | 0.43 | -0.18 | 145 |
| 28 | [Infrared sauna] | 0.43 | -0.25 | 169 |
| 29 | [Bentonite clay] | 0.42 | -0.08 | 66 |
| 30 | [Traditional sauna] | 0.23 | -0.43 | 118 |
| 31 | [Wim Hof without cold] | 0.21 | -0.32 | 104 |
| 32 | [Rife] | 0.17 | -0.62 | 24 |
| 33 | [Lightning process] | -0.23 | -0.77 | 13 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Other brain retraining] | 1.50 | -0.01 | 173 |
| 2 | [Prayer] | 1.20 | -0.02 | 368 |
| 3 | [Meditation] | 1.05 | -0.02 | 708 |
| 4 | [Wim Hof with cold] | 0.80 | -0.16 | 185 |
| 5 | [EMDR] | 0.74 | -0.15 | 145 |
| 6 | [Gupta program] | 0.65 | -0.07 | 57 |
| 7 | [Acupuncture] | 0.60 | -0.18 | 401 |
| 8 | [DNRS] | 0.53 | -0.11 | 36 |
| 9 | [CBT] | 0.53 | -0.13 | 405 |
| 10 | [Wim Hof without cold] | 0.21 | -0.32 | 104 |
| 11 | [Lightning process] | -0.23 | -0.77 | 13 |
*This survey did not ask whether methylene blue was taken via IV or swallowed into the body.
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Stem cells] | 1.67 | 0.00 | 12 |
| 2 | [HBOT >1.5 ATA] | 1.25 | -0.12 | 69 |
| 3 | [PLEX] | 1.00 | -0.20 | 5 |
| 4 | [EBOO] | 0.94 | 0.00 | 17 |
| 5 | [Rapamycin] | 0.88 | 0.00 | 8 |
| 6 | [HBOT <=1.5 ATA] | 0.75 | -0.15 | 71 |
| 7 | [IV vitamins] | 0.62 | -0.07 | 149 |
| 8 | [HELP apheresis] | 0.60 | -0.47 | 15 |
| 9 | [Methylene blue] | 0.58 | -0.14 | 64 |
| 10 | [IV ozone] | 0.53 | -0.15 | 53 |
| 11 | [IVIG] | 0.52 | -0.17 | 23 |
| 12 | [SGB] | 0.50 | -0.12 | 34 |
| 13 | [Corticosteroids] | 0.48 | -0.46 | 328 |
| 14 | [Inuspheresis] | 0.44 | -0.33 | 9 |
| 15 | [SCIG] | 0.33 | -0.50 | 6 |
| 16 | [Biologic] | 0.23 | -0.46 | 13 |
| 17 | [DMARD] | 0.13 | -0.47 | 15 |
| 18 | [Immunoadsorption] | -0.71 | -0.86 | 7 |
| 19 | [Methotextrate] | -0.87 | -1.20 | 15 |
Chronic Lyme treatments such as HBOT, methylene blue, IV ozone, and monolaurin are included. Amphotericin, Canesten, Econazole, etc. are anti-fungals.
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Favipiravir] | 1.33 | 0.00 | 3 |
| 2 | [HBOT >1.5 ATA] | 1.25 | -0.12 | 69 |
| 3 | [Ivermectin] | 0.91 | -0.14 | 245 |
| 4 | [Rapamycin] | 0.88 | 0.00 | 8 |
| 5 | [Monoclonals] | 0.88 | -0.12 | 25 |
| 6 | [HBOT <=1.5 ATA] | 0.75 | -0.15 | 71 |
| 7 | [Alinia] | 0.62 | -0.38 | 8 |
| 8 | [Methylene blue] | 0.58 | -0.14 | 64 |
| 9 | [Oil of oregano] | 0.54 | -0.09 | 139 |
| 10 | [Plaquenil] | 0.54 | -0.31 | 83 |
| 11 | [IV ozone] | 0.53 | -0.15 | 53 |
| 12 | [Paxlovid] | 0.53 | -0.23 | 123 |
| 13 | [Nigella sativa oil] | 0.50 | -0.06 | 126 |
| 14 | [Nigella sativa capsules] | 0.47 | -0.02 | 111 |
| 15 | [Molnupiravir] | 0.44 | 0.00 | 9 |
| 16 | [Cat's claw] | 0.44 | -0.06 | 72 |
| 17 | [Aciclovir, Famciclovir, Valtrex, Valcyte] | 0.43 | -0.19 | 172 |
| 18 | [Lavender] | 0.42 | -0.04 | 106 |
| 19 | [Amphotericin, Canesten, Econazole, Fluconazol... | 0.41 | -0.26 | 199 |
| 20 | [Nigella sativa seed] | 0.40 | -0.04 | 25 |
| 21 | [Lion's mane] | 0.36 | -0.13 | 241 |
| 22 | [Biocidin] | 0.29 | -0.21 | 24 |
| 23 | [Monolaurin] | 0.24 | -0.12 | 72 |
| 24 | [Tetracyclines, Fluoroquinolones, Penicillins,... | 0.02 | -0.54 | 524 |
'Antibiotic unknown type' = The surveyee doesn't know what antibiotic they took.
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Rapamycin] | 0.88 | 0.00 | 8 |
| 2 | [Metronidazole] | 0.39 | -0.39 | 28 |
| 3 | [Sulfonamides] | 0.26 | -0.32 | 19 |
| 4 | [Clindamycin] | 0.23 | -0.64 | 22 |
| 5 | [Antibiotic unknown type] | 0.17 | -0.48 | 48 |
| 6 | [Tetracyclines] | 0.16 | -0.44 | 121 |
| 7 | [Cephalosporins] | 0.12 | -0.56 | 16 |
| 8 | [Macrolides] | 0.00 | -0.58 | 50 |
| 9 | [Penicillins] | -0.03 | -0.51 | 121 |
| 10 | [Other antibiotic] | -0.22 | -0.64 | 36 |
| 11 | [Fluoroquinolones] | -0.33 | -0.75 | 52 |
| 12 | [Aminoglycosides] | -0.67 | -1.00 | 3 |
| 13 | [Nitrofurantoin] | -0.88 | -1.25 | 8 |
Surveyees may have answered in an acute COVID-19 context or outside of an acute COVID-19 context.
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Favipiravir] | 1.33 | 0.00 | 3 |
| 2 | [Ivermectin] | 0.91 | -0.14 | 245 |
| 3 | [Monoclonals] | 0.88 | -0.12 | 25 |
| 4 | [Tollovid] | 0.59 | -0.09 | 22 |
| 5 | [Plaquenil] | 0.54 | -0.31 | 83 |
| 6 | [Paxlovid] | 0.53 | -0.23 | 123 |
| 7 | [Melatonin] | 0.50 | -0.17 | 602 |
| 8 | [TWC detox] | 0.50 | -0.10 | 20 |
| 9 | [Vitamin D] | 0.49 | -0.04 | 1009 |
| 10 | [Molnupiravir] | 0.44 | 0.00 | 9 |
| 11 | [Vedicinals9] | 0.29 | -0.33 | 21 |
Surveyees may have answered in an acute COVID-19 context or outside of an acute COVID-19 context.
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [HCG] | 0.67 | 0.00 | 3 |
| 2 | [TRT] | 0.57 | -0.18 | 56 |
| 3 | [St. John's Wort] | 0.41 | -0.23 | 61 |
| 4 | [Ashwagandha] | 0.29 | -0.19 | 356 |
| 5 | [Elavil, Doxepin, Pamelor, Clomipramine, Clomi... | -0.24 | -0.63 | 216 |
| 6 | [Remeron, Seroquel, Wellbutrin] | -0.25 | -0.68 | 316 |
| 7 | [Celexa, Lexapro, Fluvoxamine, Prozac, Paxil, ... | -0.30 | -0.74 | 553 |
| 8 | [Cymbalta, Effexor] | -0.39 | -0.85 | 175 |
Surveyees were instructed to leave answers blank if they weren't comfortable answering questions about CBD (which may be illegal in their jurisdiction).
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Psychedelic mushrooms] | 0.73 | -0.22 | 112 |
| 2 | [Patches] | 0.63 | -0.28 | 159 |
| 3 | [CBD with THC] | 0.39 | -0.40 | 348 |
| 4 | [CBD without THC] | 0.39 | -0.15 | 346 |
| 5 | [Other nicotine] | 0.38 | -0.22 | 82 |
| 6 | [Cigarettes] | 0.05 | -0.28 | 80 |
| 7 | [Vaping] | 0.04 | -0.30 | 97 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Other chelation] | 0.85 | -0.09 | 33 |
| 2 | [EDTA] | 0.56 | -0.22 | 18 |
| 3 | [Activated charcoal] | 0.49 | -0.09 | 107 |
| 4 | [DTPA] | -0.25 | -0.25 | 4 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Water and salt] | 1.02 | -0.02 | 723 |
| 2 | [Drinking water] | 0.87 | -0.00 | 411 |
| 3 | [Guanfacine] | 0.73 | -0.36 | 56 |
| 4 | [Compression garments] | 0.73 | -0.05 | 438 |
| 5 | [Beta blockers] | 0.69 | -0.34 | 369 |
| 6 | [Sleeping with head of bed elevated] | 0.53 | -0.08 | 336 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Ivermectin] | 0.91 | -0.14 | 245 |
| 2 | [Magnesium] | 0.75 | -0.06 | 935 |
| 3 | [Plaquenil] | 0.54 | -0.31 | 83 |
| 4 | [NAC] | 0.52 | -0.10 | 551 |
| 5 | [Quercetin] | 0.52 | -0.06 | 570 |
| 6 | [TWC detox] | 0.50 | -0.10 | 20 |
| 7 | [Nigella sativa oil] | 0.50 | -0.06 | 126 |
| 8 | [Vitamin D] | 0.49 | -0.04 | 1009 |
| 9 | [Nigella sativa capsules] | 0.47 | -0.02 | 111 |
| 10 | [Curcumin] | 0.46 | -0.05 | 666 |
| 11 | [Zinc] | 0.43 | -0.03 | 660 |
| 12 | [Vitamin C] | 0.42 | -0.04 | 805 |
| 13 | [Nigella sativa seed] | 0.40 | -0.04 | 25 |
| 14 | [Augmented NAC] | 0.36 | -0.13 | 188 |
| 15 | [Vedicinals9] | 0.29 | -0.33 | 21 |
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Avacen] | 3.00 | 0.00 | 1 |
| 2 | [Urotherapy] | 1.50 | 0.00 | 4 |
| 3 | [ASEA Redox] | 1.18 | -0.27 | 11 |
| 4 | [Chlorine dioxide] | 1.09 | 0.00 | 23 |
| 5 | [Cardio Miracle] | 0.90 | 0.00 | 10 |
| 6 | [Root wellness] | 0.75 | -0.08 | 12 |
| 7 | [Gupta program] | 0.65 | -0.07 | 57 |
| 8 | [Kangen water] | 0.56 | 0.00 | 9 |
| 9 | [DNRS] | 0.53 | -0.11 | 36 |
| 10 | [TWC detox] | 0.50 | -0.10 | 20 |
| 11 | [Zeolite] | 0.45 | -0.07 | 82 |
| 12 | [Augmented NAC] | 0.36 | -0.13 | 188 |
| 13 | [Frequency wand] | -0.09 | -0.91 | 11 |
| 14 | [Lightning process] | -0.23 | -0.77 | 13 |
These charts show how surveyees reported their experiences with particular treatments. If the treatment had very few data points, they are usually grouped together with other similar treatments to provide combined data.
===Popularity stats=== LC 3.8% 29/771 patients PostVac 5.5% 24/440 patients MECFS 4.0% 5/126 patients
===Popularity stats=== LC 6.0% 46/771 patients PostVac 8.4% 37/440 patients MECFS 13.5% 17/126 patients
===Popularity stats=== LC 4.0% 31/771 patients PostVac 6.1% 27/440 patients MECFS 13.5% 17/126 patients
===Popularity stats=== LC 5.3% 41/771 patients PostVac 9.1% 40/440 patients MECFS 10.3% 13/126 patients
===Popularity stats=== LC 4.2% 32/771 patients PostVac 6.6% 29/440 patients MECFS 4.0% 5/126 patients
===Popularity stats=== LC 6.5% 50/771 patients PostVac 4.3% 19/440 patients MECFS 5.6% 7/126 patients
===Popularity stats=== LC 5.7% 44/771 patients PostVac 11.1% 49/440 patients MECFS 7.1% 9/126 patients
===Popularity stats=== LC 12.3% 95/771 patients PostVac 7.0% 31/440 patients MECFS 9.5% 12/126 patients
===Popularity stats=== LC 4.5% 35/771 patients PostVac 1.4% 6/440 patients MECFS 8.7% 11/126 patients
===Popularity stats=== LC 43.3% 334/771 patients PostVac 39.1% 172/440 patients MECFS 42.9% 54/126 patients
===Popularity stats=== LC 41.0% 316/771 patients PostVac 43.2% 190/440 patients MECFS 31.0% 39/126 patients
===Popularity stats=== LC 49.5% 382/771 patients PostVac 45.2% 199/440 patients MECFS 46.0% 58/126 patients
===Popularity stats=== LC 26.8% 207/771 patients PostVac 31.4% 138/440 patients MECFS 25.4% 32/126 patients
Heparin, Eliquis / Apixiban, Clopidogrel, Xarelto, Sulodexide
===Popularity stats=== LC 1.9% 15/771 patients PostVac 3.6% 16/440 patients MECFS 2.4% 3/126 patients
===Popularity stats=== LC 4.0% 31/771 patients PostVac 5.2% 23/440 patients MECFS 1.6% 2/126 patients
===Popularity stats=== LC 3.4% 26/771 patients PostVac 6.6% 29/440 patients MECFS 3.2% 4/126 patients
===Popularity stats=== LC 35.0% 270/771 patients PostVac 47.7% 210/440 patients MECFS 19.8% 25/126 patients
===Popularity stats=== LC 17.8% 137/771 patients PostVac 22.3% 98/440 patients MECFS 11.1% 14/126 patients
===Popularity stats=== LC 7.0% 54/771 patients PostVac 10.5% 46/440 patients MECFS 4.8% 6/126 patients
===Popularity stats=== LC 0.4% 3/771 patients PostVac 0.0% 0/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 4.2% 32/771 patients PostVac 4.1% 18/440 patients MECFS 4.8% 6/126 patients
===Popularity stats=== LC 0.8% 6/771 patients PostVac 3.6% 16/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 0.1% 1/771 patients PostVac 0.7% 3/440 patients MECFS 1.6% 2/126 patients
Data on PLEX is also available from the Risk Factors Survey:
===Popularity stats=== LC 0.1% 1/771 patients PostVac 0.9% 4/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 0.8% 6/771 patients PostVac 2.0% 9/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 0.5% 4/771 patients PostVac 0.9% 4/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 0.1% 1/771 patients PostVac 1.4% 6/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 1.9% 15/771 patients PostVac 6.1% 27/440 patients MECFS 8.7% 11/126 patients
===Popularity stats=== LC 3.1% 24/771 patients PostVac 1.8% 8/440 patients MECFS 1.6% 2/126 patients
===Popularity stats=== LC 0.5% 4/771 patients PostVac 1.4% 6/440 patients MECFS 1.6% 2/126 patients
===Popularity stats=== LC 8.4% 65/771 patients PostVac 14.5% 64/440 patients MECFS 15.9% 20/126 patients
===Popularity stats=== LC 4.8% 37/771 patients PostVac 9.8% 43/440 patients MECFS 10.3% 13/126 patients
===Popularity stats=== LC 0.9% 7/771 patients PostVac 2.0% 9/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 2.2% 17/771 patients PostVac 9.1% 40/440 patients MECFS 5.6% 7/126 patients
HBOT <=1.5 ATA, HBOT >1.5 ATA
===Popularity stats=== LC 4.2% 32/771 patients PostVac 7.3% 32/440 patients MECFS 5.6% 7/126 patients
===Popularity stats=== LC 4.7% 36/771 patients PostVac 5.7% 25/440 patients MECFS 6.3% 8/126 patients
===Popularity stats=== LC 6.1% 47/771 patients PostVac 9.5% 42/440 patients MECFS 14.3% 18/126 patients
===Popularity stats=== LC 0.5% 4/771 patients PostVac 2.3% 10/440 patients MECFS 3.2% 4/126 patients
===Popularity stats=== LC 0.3% 2/771 patients PostVac 0.5% 2/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 1.0% 8/771 patients PostVac 4.8% 21/440 patients MECFS 3.2% 4/126 patients
===Popularity stats=== LC 37.0% 285/771 patients PostVac 26.1% 115/440 patients MECFS 30.2% 38/126 patients
Note: surveyees may have misinterpreted the survey question ('Increased intake of water and salt'), use the data with caution. The higher popularity of this intervention suggests that people without POTS or dysautonomia answered this question and have a different interpretation as to what this intervention is.
===Popularity stats=== LC 59.9% 462/771 patients PostVac 46.1% 203/440 patients MECFS 46.0% 58/126 patients
===Popularity stats=== LC 36.2% 279/771 patients PostVac 22.7% 100/440 patients MECFS 25.4% 32/126 patients
===Popularity stats=== LC 25.2% 194/771 patients PostVac 26.4% 116/440 patients MECFS 20.6% 26/126 patients
===Popularity stats=== LC 20.6% 159/771 patients PostVac 33.9% 149/440 patients MECFS 15.9% 20/126 patients
Do people with lower severity respond better to corticosteroids? Current severity 4 or less | Average (mean) score: 0.52 | n = 120 Current severity 5 or more | Average (mean) score: 0.44 | n = 165
===Popularity stats=== LC 0.5% 4/771 patients PostVac 2.5% 11/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 0.4% 3/771 patients PostVac 2.3% 10/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 0.9% 7/771 patients PostVac 1.8% 8/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 11.8% 91/771 patients PostVac 31.1% 137/440 patients MECFS 13.5% 17/126 patients
===Popularity stats=== LC 3.9% 30/771 patients PostVac 10.0% 44/440 patients MECFS 7.1% 9/126 patients
===Popularity stats=== LC 0.3% 2/771 patients PostVac 0.9% 4/440 patients MECFS 1.6% 2/126 patients
===Popularity stats=== LC 0.6% 5/771 patients PostVac 0.0% 0/440 patients MECFS 2.4% 3/126 patients
===Popularity stats=== LC 8.6% 66/771 patients PostVac 7.3% 32/440 patients MECFS 10.3% 13/126 patients
===Popularity stats=== LC 0.1% 1/771 patients PostVac 0.2% 1/440 patients MECFS 1.6% 2/126 patients
===Popularity stats=== LC 2.6% 20/771 patients PostVac 4.3% 19/440 patients MECFS 4.8% 6/126 patients
===Popularity stats=== LC 1.0% 8/771 patients PostVac 0.7% 3/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 12.8% 99/771 patients PostVac 4.5% 20/440 patients MECFS 3.2% 4/126 patients
===Popularity stats=== LC 0.8% 6/771 patients PostVac 0.5% 2/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 1.2% 9/771 patients PostVac 3.4% 15/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 2.5% 19/771 patients PostVac 0.5% 2/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 1.6% 12/771 patients PostVac 2.0% 9/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 7.9% 61/771 patients PostVac 12.0% 53/440 patients MECFS 10.3% 13/126 patients
===Popularity stats=== LC 6.4% 49/771 patients PostVac 11.4% 50/440 patients MECFS 5.6% 7/126 patients
===Popularity stats=== LC 14.5% 112/771 patients PostVac 23.2% 102/440 patients MECFS 15.9% 20/126 patients
===Popularity stats=== LC 21.3% 164/771 patients PostVac 25.2% 111/440 patients MECFS 22.2% 28/126 patients
===Popularity stats=== LC 4.9% 38/771 patients PostVac 4.3% 19/440 patients MECFS 14.3% 18/126 patients
===Popularity stats=== LC 8.3% 64/771 patients PostVac 13.9% 61/440 patients MECFS 10.3% 13/126 patients
===Popularity stats=== LC 8.4% 65/771 patients PostVac 11.1% 49/440 patients MECFS 11.1% 14/126 patients
===Popularity stats=== LC 7.0% 54/771 patients PostVac 7.7% 34/440 patients MECFS 4.0% 5/126 patients
===Popularity stats=== LC 29.1% 224/771 patients PostVac 26.8% 118/440 patients MECFS 21.4% 27/126 patients
===Popularity stats=== LC 5.4% 42/771 patients PostVac 2.3% 10/440 patients MECFS 3.2% 4/126 patients
===Popularity stats=== LC 3.8% 29/771 patients PostVac 3.4% 15/440 patients MECFS 7.9% 10/126 patients
===Popularity stats=== LC 8.8% 68/771 patients PostVac 8.0% 35/440 patients MECFS 4.8% 6/126 patients
===Popularity stats=== LC 3.0% 23/771 patients PostVac 6.4% 28/440 patients MECFS 2.4% 3/126 patients
===Popularity stats=== LC 6.5% 50/771 patients PostVac 4.3% 19/440 patients MECFS 6.3% 8/126 patients
===Popularity stats=== LC 1.8% 14/771 patients PostVac 2.5% 11/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 10.1% 78/771 patients PostVac 10.0% 44/440 patients MECFS 5.6% 7/126 patients
===Popularity stats=== LC 37.4% 288/771 patients PostVac 29.1% 128/440 patients MECFS 23.8% 30/126 patients
===Popularity stats=== LC 21.3% 164/771 patients PostVac 15.7% 69/440 patients MECFS 10.3% 13/126 patients
===Popularity stats=== LC 31.9% 246/771 patients PostVac 30.0% 132/440 patients MECFS 15.1% 19/126 patients
===Popularity stats=== LC 19.1% 147/771 patients PostVac 12.5% 55/440 patients MECFS 12.7% 16/126 patients
===Popularity stats=== LC 29.8% 230/771 patients PostVac 24.5% 108/440 patients MECFS 14.3% 18/126 patients
===Popularity stats=== LC 4.2% 32/771 patients PostVac 5.0% 22/440 patients MECFS 6.3% 8/126 patients
===Popularity stats=== LC 5.6% 43/771 patients PostVac 4.5% 20/440 patients MECFS 4.0% 5/126 patients
===Popularity stats=== LC 10.4% 80/771 patients PostVac 9.3% 41/440 patients MECFS 8.7% 11/126 patients
Note: Some anti-histamine drugs (e.g. Doxepin, Seroquel) are listed under anti-depressants above.
===Popularity stats=== LC 3.1% 24/771 patients PostVac 4.5% 20/440 patients MECFS 2.4% 3/126 patients
===Popularity stats=== LC 3.9% 30/771 patients PostVac 3.9% 17/440 patients MECFS 7.1% 9/126 patients
===Popularity stats=== LC 26.5% 204/771 patients PostVac 27.0% 119/440 patients MECFS 27.0% 34/126 patients
===Popularity stats=== LC 6.4% 49/771 patients PostVac 15.2% 67/440 patients MECFS 7.9% 10/126 patients
===Popularity stats=== LC 5.4% 42/771 patients PostVac 14.1% 62/440 patients MECFS 5.6% 7/126 patients
===Popularity stats=== LC 1.7% 13/771 patients PostVac 2.5% 11/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 16.9% 130/771 patients PostVac 26.6% 117/440 patients MECFS 24.6% 31/126 patients
===Popularity stats=== LC 26.2% 202/771 patients PostVac 28.4% 125/440 patients MECFS 23.0% 29/126 patients
===Popularity stats=== LC 1.7% 13/771 patients PostVac 2.3% 10/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 4.5% 35/771 patients PostVac 5.9% 26/440 patients MECFS 8.7% 11/126 patients
===Popularity stats=== LC 25.0% 193/771 patients PostVac 26.4% 116/440 patients MECFS 29.4% 37/126 patients
===Popularity stats=== LC 24.9% 192/771 patients PostVac 29.1% 128/440 patients MECFS 22.2% 28/126 patients
===Popularity stats=== LC 45.3% 349/771 patients PostVac 40.9% 180/440 patients MECFS 62.7% 79/126 patients
===Popularity stats=== LC 47.6% 367/771 patients PostVac 55.7% 245/440 patients MECFS 42.9% 54/126 patients
===Popularity stats=== LC 13.7% 106/771 patients PostVac 19.3% 85/440 patients MECFS 15.9% 20/126 patients
===Popularity stats=== LC 47.9% 369/771 patients PostVac 49.5% 218/440 patients MECFS 56.3% 71/126 patients
===Popularity stats=== LC 18.2% 140/771 patients PostVac 32.7% 144/440 patients MECFS 24.6% 31/126 patients
===Popularity stats=== LC 5.4% 42/771 patients PostVac 10.9% 48/440 patients MECFS 12.7% 16/126 patients
===Popularity stats=== LC 18.4% 142/771 patients PostVac 18.6% 82/440 patients MECFS 13.5% 17/126 patients
===Popularity stats=== LC 44.7% 345/771 patients PostVac 47.0% 207/440 patients MECFS 39.7% 50/126 patients
===Popularity stats=== LC 4.0% 31/771 patients PostVac 7.5% 33/440 patients MECFS 6.3% 8/126 patients
===Popularity stats=== LC 38.8% 299/771 patients PostVac 48.4% 213/440 patients MECFS 31.0% 39/126 patients
===Popularity stats=== LC 11.5% 89/771 patients PostVac 18.4% 81/440 patients MECFS 14.3% 18/126 patients
===Popularity stats=== LC 16.5% 127/771 patients PostVac 16.4% 72/440 patients MECFS 24.6% 31/126 patients
===Popularity stats=== LC 9.3% 72/771 patients PostVac 11.6% 51/440 patients MECFS 12.7% 16/126 patients
===Popularity stats=== LC 3.0% 23/771 patients PostVac 16.4% 72/440 patients MECFS 4.8% 6/126 patients
===Popularity stats=== LC 53.7% 414/771 patients PostVac 46.4% 204/440 patients MECFS 50.8% 64/126 patients
===Popularity stats=== LC 39.3% 303/771 patients PostVac 52.3% 230/440 patients MECFS 29.4% 37/126 patients
===Popularity stats=== LC 16.7% 129/771 patients PostVac 27.3% 120/440 patients MECFS 13.5% 17/126 patients
===Popularity stats=== LC 2.6% 20/771 patients PostVac 9.5% 42/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 3.4% 26/771 patients PostVac 5.5% 24/440 patients MECFS 8.7% 11/126 patients
===Popularity stats=== LC 69.4% 535/771 patients PostVac 64.5% 284/440 patients MECFS 73.0% 92/126 patients
*Intravenous vitamin C is listed elsewhere as "IV vitamin C".
===Popularity stats=== LC 59.9% 462/771 patients PostVac 60.0% 264/440 patients MECFS 62.7% 79/126 patients
===Popularity stats=== LC 75.1% 579/771 patients PostVac 75.2% 331/440 patients MECFS 78.6% 99/126 patients
===Popularity stats=== LC 22.6% 174/771 patients PostVac 30.7% 135/440 patients MECFS 25.4% 32/126 patients
===Popularity stats=== LC 43.7% 337/771 patients PostVac 40.5% 178/440 patients MECFS 41.3% 52/126 patients
===Popularity stats=== LC 68.7% 530/771 patients PostVac 70.2% 309/440 patients MECFS 76.2% 96/126 patients
===Popularity stats=== LC 47.3% 365/771 patients PostVac 53.2% 234/440 patients MECFS 48.4% 61/126 patients
CBD is found above, not here.
===Popularity stats=== LC 8.0% 62/771 patients PostVac 6.4% 28/440 patients MECFS 5.6% 7/126 patients
===Popularity stats=== LC 5.2% 40/771 patients PostVac 8.4% 37/440 patients MECFS 2.4% 3/126 patients
===Popularity stats=== LC 12.7% 98/771 patients PostVac 11.4% 50/440 patients MECFS 8.7% 11/126 patients
===Popularity stats=== LC 6.2% 48/771 patients PostVac 6.8% 30/440 patients MECFS 3.2% 4/126 patients
===Popularity stats=== LC 9.5% 73/771 patients PostVac 6.1% 27/440 patients MECFS 9.5% 12/126 patients
===Popularity stats=== LC 40.7% 314/771 patients PostVac 37.0% 163/440 patients MECFS 31.0% 39/126 patients
===Popularity stats=== LC 35.4% 273/771 patients PostVac 35.5% 156/440 patients MECFS 50.0% 63/126 patients
===Popularity stats=== LC 20.1% 155/771 patients PostVac 16.1% 71/440 patients MECFS 24.6% 31/126 patients
===Popularity stats=== LC 9.6% 74/771 patients PostVac 8.2% 36/440 patients MECFS 15.1% 19/126 patients
===Popularity stats=== LC 5.1% 39/771 patients PostVac 5.5% 24/440 patients MECFS 5.6% 7/126 patients
===Popularity stats=== LC 0.9% 7/771 patients PostVac 2.3% 10/440 patients MECFS 1.6% 2/126 patients
===Popularity stats=== LC 6.5% 50/771 patients PostVac 8.6% 38/440 patients MECFS 4.8% 6/126 patients
===Popularity stats=== LC 10.8% 83/771 patients PostVac 10.0% 44/440 patients MECFS 19.0% 24/126 patients
===Popularity stats=== LC 15.7% 121/771 patients PostVac 15.9% 70/440 patients MECFS 14.3% 18/126 patients
===Popularity stats=== LC 4.8% 37/771 patients PostVac 10.2% 45/440 patients MECFS 10.3% 13/126 patients
===Popularity stats=== LC 18.4% 142/771 patients PostVac 25.7% 113/440 patients MECFS 16.7% 21/126 patients
===Popularity stats=== LC 35.0% 270/771 patients PostVac 44.1% 194/440 patients MECFS 42.9% 54/126 patients
===Popularity stats=== LC 14.8% 114/771 patients PostVac 18.0% 79/440 patients MECFS 11.9% 15/126 patients
===Popularity stats=== LC 8.7% 67/771 patients PostVac 8.9% 39/440 patients MECFS 5.6% 7/126 patients
===Popularity stats=== LC 2.6% 20/771 patients PostVac 3.4% 15/440 patients MECFS 3.2% 4/126 patients
===Popularity stats=== LC 4.3% 33/771 patients PostVac 5.0% 22/440 patients MECFS 4.0% 5/126 patients
===Popularity stats=== LC 50.5% 389/771 patients PostVac 44.3% 195/440 patients MECFS 50.0% 63/126 patients
===Popularity stats=== LC 65.4% 504/771 patients PostVac 60.0% 264/440 patients MECFS 63.5% 80/126 patients
===Popularity stats=== LC 28.4% 219/771 patients PostVac 16.4% 72/440 patients MECFS 34.9% 44/126 patients
===Popularity stats=== LC 68.2% 526/771 patients PostVac 53.6% 236/440 patients MECFS 72.2% 91/126 patients
===Popularity stats=== LC 63.8% 492/771 patients PostVac 34.8% 153/440 patients MECFS 70.6% 89/126 patients
===Popularity stats=== LC 32.3% 249/771 patients PostVac 25.0% 110/440 patients MECFS 36.5% 46/126 patients
===Popularity stats=== LC 24.8% 191/771 patients PostVac 30.7% 135/440 patients MECFS 33.3% 42/126 patients
===Popularity stats=== LC 56.0% 432/771 patients PostVac 43.4% 191/440 patients MECFS 67.5% 85/126 patients
===Popularity stats=== LC 10.8% 83/771 patients PostVac 10.2% 45/440 patients MECFS 13.5% 17/126 patients
===Popularity stats=== LC 2.7% 21/771 patients PostVac 1.1% 5/440 patients MECFS 7.9% 10/126 patients
===Popularity stats=== LC 4.2% 32/771 patients PostVac 2.5% 11/440 patients MECFS 11.1% 14/126 patients
===Popularity stats=== LC 1.2% 9/771 patients PostVac 0.5% 2/440 patients MECFS 1.6% 2/126 patients
===Popularity stats=== LC 8.8% 68/771 patients PostVac 6.8% 30/440 patients MECFS 4.8% 6/126 patients
===Popularity stats=== LC 15.0% 116/771 patients PostVac 11.8% 52/440 patients MECFS 13.5% 17/126 patients
===Popularity stats=== LC 12.2% 94/771 patients PostVac 10.0% 44/440 patients MECFS 27.8% 35/126 patients
===Popularity stats=== LC 26.3% 203/771 patients PostVac 34.3% 151/440 patients MECFS 37.3% 47/126 patients
===Popularity stats=== LC 11.0% 85/771 patients PostVac 23.0% 101/440 patients MECFS 20.6% 26/126 patients
===Popularity stats=== LC 7.0% 54/771 patients PostVac 10.2% 45/440 patients MECFS 7.9% 10/126 patients
===Popularity stats=== LC 0.8% 6/771 patients PostVac 1.1% 5/440 patients MECFS 1.6% 2/126 patients
===Popularity stats=== LC 6.1% 47/771 patients PostVac 8.2% 36/440 patients MECFS 12.7% 16/126 patients
===Popularity stats=== LC 6.7% 52/771 patients PostVac 14.1% 62/440 patients MECFS 24.6% 31/126 patients
===Popularity stats=== LC 5.6% 43/771 patients PostVac 9.8% 43/440 patients MECFS 15.1% 19/126 patients
===Popularity stats=== LC 0.5% 4/771 patients PostVac 2.3% 10/440 patients MECFS 7.9% 10/126 patients
===Popularity stats=== LC 1.4% 11/771 patients PostVac 3.0% 13/440 patients MECFS 2.4% 3/126 patients
===Popularity stats=== LC 2.3% 18/771 patients PostVac 2.5% 11/440 patients MECFS 1.6% 2/126 patients
===Popularity stats=== LC 27.0% 208/771 patients PostVac 20.9% 92/440 patients MECFS 25.4% 32/126 patients
===Popularity stats=== LC 1.7% 13/771 patients PostVac 2.0% 9/440 patients MECFS 1.6% 2/126 patients
===Popularity stats=== LC 2.7% 21/771 patients PostVac 8.9% 39/440 patients MECFS 4.8% 6/126 patients
===Popularity stats=== LC 0.5% 4/771 patients PostVac 3.2% 14/440 patients MECFS 4.0% 5/126 patients
===Popularity stats=== LC 0.0% 0/771 patients PostVac 0.7% 3/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 3.4% 26/771 patients PostVac 10.5% 46/440 patients MECFS 7.9% 10/126 patients
===Popularity stats=== LC 0.1% 1/771 patients PostVac 2.3% 10/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 0.0% 0/771 patients PostVac 0.2% 1/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 0.4% 3/771 patients PostVac 1.6% 7/440 patients MECFS 0.0% 0/126 patients
===Popularity stats=== LC 0.8% 6/771 patients PostVac 0.5% 2/440 patients MECFS 0.8% 1/126 patients
This data may be biased as many users blocked the survey recruiter on Facebook and/or participate in the multi-level marketing scheme that sells this product.
===Popularity stats=== LC 0.1% 1/771 patients PostVac 2.0% 9/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 0.3% 2/771 patients PostVac 2.0% 9/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 0.9% 7/771 patients PostVac 2.7% 12/440 patients MECFS 0.8% 1/126 patients
===Popularity stats=== LC 1.9% 15/771 patients PostVac 2.3% 10/440 patients MECFS 5.6% 7/126 patients
*Note: Some people lose their ability to tolerate heat (e.g. hot showers) after they develop chronic illness. What works for somebody else may not be appropriate for you.
===Popularity stats=== LC 7.1% 55/771 patients PostVac 9.8% 43/440 patients MECFS 15.9% 20/126 patients
===Popularity stats=== LC 10.2% 79/771 patients PostVac 15.5% 68/440 patients MECFS 17.5% 22/126 patients
===Popularity stats=== LC 12.1% 93/771 patients PostVac 19.3% 85/440 patients MECFS 23.0% 29/126 patients
Around 85% engaged with this question while others did not. It is possible that the question is interpreted differently between surveyees.
===Popularity stats=== LC 89.4% 689/771 patients PostVac 86.8% 382/440 patients MECFS 80.2% 101/126 patients
Number of treatments tried versus biological sex: Female: 31.5 Male: 28.6
Age distribution in Long COVID surveyees
Age distribution in COVID vaccine injured surveyees
65.4% of surveyees indicated that they were biologically female. 34.2% of surveyees indicated that they were biologically male. 0.5% of surveyees indicated that they were biologically other (e.g. intersex).
3.0 173 0.0 95 2.0 82 1.0 65 Name: Employment severity current, dtype: int64
The severity scale is as follows:
Surveyees reported 'peak' severity from the worst month of illness.
Most but not all participants were asked:
How did you find out about this survey? e.g. r/CovidLongHaulers, a specific Twitter account, etc.
If there is a pre-filled answer below that is correct, please do not change it.
Most the early participants were not asked about how they found out about the survey. The vast majority of them came from vaccine injury Facebook groups.
Note: "Reddit Long COVID" refers to Long COVID-related groups (mainly r/CovidLongHaulers) on the Reddit platform.
| Referrer | |
|---|---|
| Reddit Long COVID | 631 |
| Facebook C19 Vax Adverse Reactions | 187 |
| Youtube Raelan Agle | 126 |
| Facebook Long COVID | 94 |
| Reddit Post Vax | 91 |
| Facebook Canadian Vccn | 52 |
| 38 | |
| SickAndAbandoned.com + LongHaulWiki.com | 36 |
| Unknown | 33 |
| Discord | 13 |
| Health Rising forums | 11 |
| Word of mouth | 9 |
| 4 | |
| Reddit r/LongHaulersRecovery | 4 |
| 3 | |
| 2 | |
| Facebook VASE family | 1 |
| Reddit PSSD | 1 |
| Youtube Unknown | 1 |
Please note that the recruitment strategy for this survey was quite different than previous surveys such as the Risk Factors Survey. (Data on the Risk Factors survey's recruitment can be found on slide 68 here: http://sickandabandoned.com/wp-content/uploads/2023/06/SAA-Risk-Factors-Survey-FULL.pdf )
This survey did not have participants from the two largest vaccine injured Facebook groups.
"No light sensitivity" = surveyee answered "None of the above". They may actually have light sensitivity but they did not select any of the avoidance behaviours in the checkboxes above.
The tables below show the percentage of each group that selected the checkbox.
The general trend is that avoidance behaviours increased with higher severity of the symptom; however, not all surveyees with the highest reported severity engaged in all of the avoidance behaviours.
| Sunglasses | Avoided outdoors | Avoided bright environments | No light sensitivity | Earpro | Avoided loud environments | No sound sensitivity | |
|---|---|---|---|---|---|---|---|
| Peak sound sensitivity | |||||||
| -1.0 | 0.076577 | 0.081081 | 0.121622 | 0.819820 | 0.036036 | 0.072072 | 0.900901 |
| 0.0 | 0.082192 | 0.232877 | 0.356164 | 0.589041 | 0.095890 | 0.219178 | 0.739726 |
| 1.0 | 0.209402 | 0.286325 | 0.521368 | 0.393162 | 0.306383 | 0.612766 | 0.293617 |
| 2.0 | 0.205993 | 0.367041 | 0.591760 | 0.329588 | 0.434944 | 0.762082 | 0.159851 |
| 3.0 | 0.301639 | 0.488525 | 0.724590 | 0.209836 | 0.594771 | 0.872549 | 0.055556 |
| 4.0 | 0.467662 | 0.676617 | 0.800995 | 0.104478 | 0.712871 | 0.900990 | 0.019802 |
| Sunglasses | Avoided outdoors | Avoided bright environments | No light sensitivity | Earpro | Avoided loud environments | No sound sensitivity | |
|---|---|---|---|---|---|---|---|
| Peak light sensitivity | |||||||
| -1.0 | 0.021008 | 0.033613 | 0.042017 | 0.928571 | 0.125523 | 0.238494 | 0.715481 |
| 0.0 | 0.056604 | 0.094340 | 0.169811 | 0.773585 | 0.226415 | 0.396226 | 0.509434 |
| 1.0 | 0.128205 | 0.273504 | 0.474359 | 0.418803 | 0.365957 | 0.612766 | 0.285106 |
| 2.0 | 0.218638 | 0.419355 | 0.691756 | 0.222222 | 0.434164 | 0.740214 | 0.206406 |
| 3.0 | 0.396226 | 0.581132 | 0.845283 | 0.079245 | 0.533835 | 0.827068 | 0.116541 |
| 4.0 | 0.593220 | 0.728814 | 0.881356 | 0.033898 | 0.700565 | 0.875706 | 0.045198 |
Using current sensivity versus peak sensitivity
| Sunglasses | Avoided outdoors | Avoided bright environments | No light sensitivity | Earpro | Avoided loud environments | No sound sensitivity | |
|---|---|---|---|---|---|---|---|
| Current sound sensitivity | |||||||
| -1.0 | 0.115265 | 0.155763 | 0.246106 | 0.682243 | 0.100000 | 0.218750 | 0.762500 |
| 0.0 | 0.218009 | 0.303318 | 0.535545 | 0.379147 | 0.319249 | 0.624413 | 0.281690 |
| 1.0 | 0.239394 | 0.409091 | 0.630303 | 0.309091 | 0.478788 | 0.775758 | 0.124242 |
| 2.0 | 0.343891 | 0.579186 | 0.733032 | 0.190045 | 0.602679 | 0.857143 | 0.075893 |
| 3.0 | 0.387597 | 0.519380 | 0.744186 | 0.178295 | 0.713178 | 0.875969 | 0.054264 |
| 4.0 | 0.411765 | 0.735294 | 0.823529 | 0.058824 | 0.676471 | 0.911765 | 0.000000 |
| Sunglasses | Avoided outdoors | Avoided bright environments | No light sensitivity | Earpro | Avoided loud environments | No sound sensitivity | |
|---|---|---|---|---|---|---|---|
| Current light sensitivity | |||||||
| -1.0 | 0.056657 | 0.118980 | 0.155807 | 0.796034 | 0.184136 | 0.342776 | 0.609065 |
| 0.0 | 0.165217 | 0.269565 | 0.508696 | 0.413043 | 0.390558 | 0.669528 | 0.257511 |
| 1.0 | 0.284345 | 0.460064 | 0.696486 | 0.194888 | 0.453674 | 0.718850 | 0.194888 |
| 2.0 | 0.407960 | 0.592040 | 0.825871 | 0.119403 | 0.559406 | 0.831683 | 0.108911 |
| 3.0 | 0.500000 | 0.657407 | 0.870370 | 0.055556 | 0.638889 | 0.824074 | 0.092593 |
| 4.0 | 0.513514 | 0.783784 | 0.891892 | 0.027027 | 0.675676 | 0.864865 | 0.054054 |
Second column is peak light sensitivity. There is a strong correlation between sound and light sensitivity.
Peak sound sensitivity -1.0 -0.424779 0.0 0.600000 1.0 1.051282 2.0 1.670370 3.0 2.444079 4.0 3.360000 Name: Peak light sensitivity, dtype: float64
-1 = do not have this symptom. 0 = minimal suffering. 4 = worst suffering imaginable
The survey asked respondents to rate their symptoms on a Likert scale.
These analyses look at possible connections between symptoms and treatment responses.
Those with severe food intolerances are more likely to report significant improvement from a low-histamine or gluten-free diet.
Food intolerances 2 or less | Average (mean) score: 0.92 | n = 226 Food intolerances 3-4 | Average (mean) score: 1.57 | n = 288
Food intolerances 2 or less | Average (mean) score: 0.85 | n = 234 Food intolerances 3-4 | Average (mean) score: 1.52 | n = 254
Food intolerances versus anti-histamines
Food intolerances 2 or less | Average (mean) score: 0.58 | n = 253 Food intolerances 3-4 | Average (mean) score: 0.76 | n = 187
It is thought that DAO enzymes will benefit those with a strong histamine intolerance. However, reported outcomes do not seem to correlate heavily with self-reported food intolerance.
Food intolerances 2 or less | Average (mean) score: 0.51 | n = 47 Food intolerances 3-4 | Average (mean) score: 0.61 | n = 84
Those with the most severe food intolerances may respond differently to benzodiazepines, a drug often prescribed for Mast Cell Activation Syndrome (MCAS). Food intolerances are associated with MCAS.
Food intolerances 2 or less | Average (mean) score: 1.11 | n = 183 Food intolerances 3-4 | Average (mean) score: 1.0 | n = 114
Food intolerances versus low-dose naltrexone (LDN)
Food intolerances 2 or less | Average (mean) score: 0.8 | n = 222 Food intolerances 3-4 | Average (mean) score: 0.48 | n = 133
HBOT >1.5 ATA versus food intolerances. Note: low sample size.
Food intolerances 2 or less | Average (mean) score: 1.14 | n = 44 Food intolerances 3-4 | Average (mean) score: 1.44 | n = 25
Food intolerances versus OMAD
Food intolerances 2 or less | Average (mean) score: 0.29 | n = 153 Food intolerances 3-4 | Average (mean) score: 0.6 | n = 121
Food intolerances versus prescription blood thinners
Do those without blood clotting/bleeding disorders report better outcomes from blood thinning drugs?!
No clotting disorder | Average (mean) score: 0.17 | n = 53 Reported clotting disorder | Average (mean) score: 1.05 | n = 111
No bleeding disorder | Average (mean) score: 0.61 | n = 109 Reported bleeding disorder | Average (mean) score: 0.95 | n = 56
Peak pain 2 or lower | Average (mean) score: 0.95 | n = 38 Peak pain 3 or higher | Average (mean) score: 0.94 | n = 88
Peak pain 2 or lower | Average (mean) score: 0.22 | n = 72 Peak pain 3 or higher | Average (mean) score: -0.03 | n = 159
Peak pain 2 or lower | Average (mean) score: 1.11 | n = 28 Peak pain 3 or higher | Average (mean) score: 0.51 | n = 78
Those who reported the most severe depression in their worst month of illness tended to report a higher rate of significant improvement.
No depression | Average (mean) score: -0.05 | n = 88 Peak depression 0-2 | Average (mean) score: -0.21 | n = 482 Peak depression 3-4 | Average (mean) score: -0.39 | n = 670
SSRIs may be slightly more effective in those who report the most severe brain fog, memory problems, or cognitive difficulties???
However, SSRIs were among the lowest-rated treatments in this survey.
No cognitive difficulties | Average (mean) score: -0.56 | n = 18 Cognitive difficulties 0-3 | Average (mean) score: -0.35 | n = 349 Cognitive difficulties 4 | Average (mean) score: -0.2 | n = 184
No cognitive difficulties | Average (mean) score: 0.12 | n = 43 Cognitive difficulties 0-3 | Average (mean) score: -0.3 | n = 791 Cognitive difficulties 4 | Average (mean) score: -0.34 | n = 415
No cognitive difficulties | Average (mean) score: 1.0 | n = 10 Cognitive difficulties 0-3 | Average (mean) score: 1.0 | n = 157 Cognitive difficulties 4 | Average (mean) score: 0.71 | n = 77
Benzodiazepines are sometimes prescribed for sleep issues.
(Ambien is also prescribed but there is too little data to perform a useful analysis.)
Sleep issues 3 or less | Average (mean) score: 1.09 | n = 185 Sleep issues 4 | Average (mean) score: 1.03 | n = 115
No POTS or feeling faint when standing up | Average (mean) score: 0.67 | n = 39 POTS 0-3 | Average (mean) score: 0.74 | n = 209 POTS 4 | Average (mean) score: 0.6 | n = 117
Compression garments / stockings
Drinking water before getting up in the morning
Sleeping with head of bed elevated
Increased intake of water and salt (Water and salt). *Note: surveyees may have misinterpreted this 'treatment', use caution when interpreting data.
The severity score is the combination of the following:
The combined score can range from -1 to 9.
High recovery = An improvement of 2.0 or more
Low recovery = An improvement of 1.0 or less (includes worsening)
HBOT may be an outlier as there is a large difference between the high and low recovery groups.
The chart below compares those with high levels of recovery versus those who little or no recovery. For the most part, both groups have tried the same treatments.
The treatments below were chosen because surveyees had very different experiences with those treatments.
Percentage with current symptom suffering rated 'worst suffering imaginable': 22.400000000000002 % | 283 out of 1263 Percentage who cannot currently walk more than 1 minute: 5.1 % | 65 out of 1271 Percentage who cannot work their old job: 38.0 % | 476 out of 1251
Note: some participants did not answer all of the survey questions. That is why the counts fluctuate.
In the chart below, there are 2 bars in between the x-axis labels 0" and "2". These bars are for 0 and 1. The labels on the x-axis correspond to the bar to the upper right of it.
The numbers inside each box represent the number of people.
Some surveyees increased along the severity scale due to a worsening of their work ability. This may suggest that work ability is not that important to these surveyees because they did not rate the past 30 days as being the worst month of their illness.
29 responses were dropped (at the beginning of all analysis) as their peak severity score was 2 or less. Please note that this skews the data towards lower recovery rates! Number of people where severity score is available: 1152 Questions for current severity were added later after some initial responses were collected. Some people are missing severity scores because they didn't know how to answer the question about walking ability or because their worst month overlapped with the past 30 days.
Severity score during worst month of illness Long COVID 6.8 | n = 771 ME/CFS 7.1 | n = 126 Vaccine injured 7.0 | n = 440 Severity score for past 30 days Long COVID 4.4 | n = 771 ME/CFS 4.8 | n = 126 Vaccine injured 4.7 | n = 440 Walking score for past 30 days (higher = greater impairment to walking ability) Long COVID 0.2 | n = 771 ME/CFS 0.3 | n = 126 Vaccine injured 0.2 | n = 440 Working score for past 30 days (higher = greater impairment to working ability) Long COVID 1.7 | n = 771 ME/CFS 2.2 | n = 126 Vaccine injured 1.8 | n = 440 Self-reported suffering for past 30 days (4 = greatest suffering imaginable) Long COVID 2.5 | n = 771 ME/CFS 2.5 | n = 126 Vaccine injured 2.7 | n = 440
Recovery, as measured by severity during worst month minus severity during the past 30 days
Severity during worst month of illness
Surprisingly, "Other pain relievers" ranked near the bottom of the list along with gabapentin, doxepin, and elavil.
Pain severity from the worst month of illness was used.
Opiates were included but the sample size is small.
Number of data points for Opiates - 88 from the group (pain is 3/4 on 0-4 scale) Number of data points for Gabapentin - 159 from the group (pain is 3/4 on 0-4 scale) Number of data points for Other pain relievers - 78 from the group (pain is 3/4 on 0-4 scale) Number of data points for Elavil - 63 from the group (pain is 3/4 on 0-4 scale) Number of data points for Doxepin - 33 from the group (pain is 3/4 on 0-4 scale) Number of data points for CBD with THC - 174 from the group (pain is 3/4 on 0-4 scale) Number of data points for CBD without THC - 178 from the group (pain is 3/4 on 0-4 scale) Number of data points for Opiates - 38 from the group (pain 2 or less) Number of data points for Gabapentin - 72 from the group (pain 2 or less) Number of data points for Other pain relievers - 28 from the group (pain 2 or less) Number of data points for Elavil - 31 from the group (pain 2 or less) Number of data points for Doxepin - 32 from the group (pain 2 or less) Number of data points for CBD with THC - 170 from the group (pain 2 or less) Number of data points for CBD without THC - 161 from the group (pain 2 or less)
Severity from the worst month of illness was used.
Number of data points for Other antihistamines - 27 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for Hydroxyzine - 60 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for DAO - 84 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for Clarinex - 28 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for Acrivastine - 49 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for Carnivore diet - 45 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for Benzodiazepines - 114 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for LDN - 133 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for Cromolyn - 40 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for Low histamine diet - 288 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for Glutenfree diet - 254 from the group (food intolerances is 3/4 on 0-4 scale) Number of data points for Other antihistamines - 41 from the group (food intolerances 2 or less) Number of data points for Hydroxyzine - 59 from the group (food intolerances 2 or less) Number of data points for DAO - 47 from the group (food intolerances 2 or less) Number of data points for Clarinex - 18 from the group (food intolerances 2 or less) Number of data points for Acrivastine - 79 from the group (food intolerances 2 or less) Number of data points for Carnivore diet - 48 from the group (food intolerances 2 or less) Number of data points for Benzodiazepines - 183 from the group (food intolerances 2 or less) Number of data points for LDN - 222 from the group (food intolerances 2 or less) Number of data points for Cromolyn - 15 from the group (food intolerances 2 or less) Number of data points for Low histamine diet - 226 from the group (food intolerances 2 or less) Number of data points for Glutenfree diet - 234 from the group (food intolerances 2 or less)
POTS = Postural Orthostatic Tachycardia Syndrome
OI = Orthostatic Intolerance
Severity from the worst month of illness was used.
Number of data points for Colchicine - 27 from the group (POTS OI is 3/4 on 0-4 scale) Number of data points for Compression garments - 290 from the group (POTS OI is 3/4 on 0-4 scale) Number of data points for Water and salt - 439 from the group (POTS OI is 3/4 on 0-4 scale) Number of data points for Drinking water - 270 from the group (POTS OI is 3/4 on 0-4 scale) Number of data points for Sleeping with head of bed elevated - 204 from the group (POTS OI is 3/4 on 0-4 scale) Number of data points for Beta blockers - 212 from the group (POTS OI is 3/4 on 0-4 scale) Number of data points for Guanfacine - 30 from the group (POTS OI is 3/4 on 0-4 scale) Number of data points for Colchicine - 27 from the group (POTS OI 2 or less) Number of data points for Compression garments - 146 from the group (POTS OI 2 or less) Number of data points for Water and salt - 281 from the group (POTS OI 2 or less) Number of data points for Drinking water - 137 from the group (POTS OI 2 or less) Number of data points for Sleeping with head of bed elevated - 129 from the group (POTS OI 2 or less) Number of data points for Beta blockers - 153 from the group (POTS OI 2 or less) Number of data points for Guanfacine - 26 from the group (POTS OI 2 or less)
Severity from the worst month of illness was used.
Number of data points for Ivermectin - 155 from the group (cognitive difficulties is 3/4 on 0-4 scale) Number of data points for Fluvoxamine - 44 from the group (cognitive difficulties is 3/4 on 0-4 scale) Number of data points for Benzodiazepines - 196 from the group (cognitive difficulties is 3/4 on 0-4 scale) Number of data points for Prozac - 67 from the group (cognitive difficulties is 3/4 on 0-4 scale) Number of data points for Ivermectin - 89 from the group (cognitive difficulties 2 or less) Number of data points for Fluvoxamine - 13 from the group (cognitive difficulties 2 or less) Number of data points for Benzodiazepines - 102 from the group (cognitive difficulties 2 or less) Number of data points for Prozac - 26 from the group (cognitive difficulties 2 or less)
Severity from the worst month of illness was used.
Number of data points for Benzodiazepines - 200 from the group (sleep issues are 3/4 on 0-4 scale) Number of data points for Ambien - 56 from the group (sleep issues are 3/4 on 0-4 scale) Number of data points for Benzodiazepines - 100 from the group (sleep issues 2 or less) Number of data points for Ambien - 17 from the group (sleep issues 2 or less)
Severity from the worst month of illness was used.
PLEASE NOTE: The sample sizes are VERY SMALL for this analysis. You should assume that the chart below is highly unreliable.
Severity from the worst month of illness was used.
Severity from the worst month of illness was used.
Loratadine (Claritin), fexofenadine (Allegra), cetirizine (Zyrtec, Benadryl Allergy One a Day Relief 🇬🇧), levocetirizine (Xyzal) and acrivastine (Benadryl Allergy Relief 🇬🇧) are H1 blockers that are sold over-the-counter in many countries.
Responders are defined as surveyees who answered either significant or mild improvement. The chart below compares pairings of some popular anti-histamines. Each row represents a group of people who failed a particular treatment/intervention (or reported that the effect was unclear). Each column represents the chances of responding to that particular intervention.
The bracketed numbers (1234) indicate the total number of people who did not respond to the treatment/intervention ('failed').
| Zyrtec | Claritin | Allegra | Acrivastine | Pepcid (H2 blocker) | |
|---|---|---|---|---|---|
| Zyrtec failed | 12.3% (106) | 15.3% (72) | 10.6% (47) | 18.2% (121) | |
| Claritin failed | 22.5% (120) | 16.2% (68) | 20.5% (39) | 28.4% (102) | |
| Allegra failed | 17.6% (74) | 6.6% (61) | 9.1% (22) | 19.1% (68) | |
| Acrivastine failed | 8.7% (46) | 8.8% (34) | 16.7% (24) | 24.2% (33) | |
| Pepcid (H2 blocker) failed | 14.7% (116) | 17.0% (88) | 16.7% (66) | 16.7% (30) |
7 diets compared
| Low histamine diet | Glutenfree diet | Plant based diet | Vegan diet | Carnivore diet | Keto diet | Anti inflammatory diet | |
|---|---|---|---|---|---|---|---|
| Low histamine diet failed | 16.7% (84) | 7.3% (55) | 8.3% (36) | 26.3% (19) | 42.4% (33) | 25.5% (47) | |
| Glutenfree diet failed | 28.6% (98) | 4.7% (64) | 8.5% (47) | 15.8% (19) | 40.0% (30) | 24.3% (37) | |
| Plant based diet failed | 40.0% (85) | 31.5% (89) | 1.5% (67) | 35.0% (20) | 44.4% (27) | 39.5% (38) | |
| Vegan diet failed | 40.0% (55) | 34.8% (66) | 5.7% (70) | 42.1% (19) | 66.7% (18) | 48.0% (25) | |
| Carnivore diet failed | 22.2% (18) | 23.8% (21) | 18.8% (16) | 21.4% (14) | 7.1% (14) | 45.5% (11) | |
| Keto diet failed | 42.4% (33) | 50.0% (36) | 31.8% (22) | 25.0% (8) | 7.1% (14) | 29.4% (17) | |
| Anti inflammatory diet failed | 16.7% (42) | 15.2% (33) | 8.0% (25) | 7.1% (14) | 0.0% (6) | 14.3% (14) |
All diets compared
| Low histamine diet | Glutenfree diet | Plant based diet | Vegan diet | AIP diet | Wahls protocol | Paleo diet | Carnivore diet | Keto diet | Anti inflammatory diet | Other diet | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Low histamine diet failed | 16.7% (84) | 7.3% (55) | 8.3% (36) | 7.1% (14) | 0.0% (3) | 30.8% (13) | 26.3% (19) | 42.4% (33) | 25.5% (47) | 50.0% (10) | |
| Glutenfree diet failed | 28.6% (98) | 4.7% (64) | 8.5% (47) | 17.6% (17) | 0.0% (5) | 26.3% (19) | 15.8% (19) | 40.0% (30) | 24.3% (37) | 40.0% (5) | |
| Plant based diet failed | 40.0% (85) | 31.5% (89) | 1.5% (67) | 20.0% (15) | 33.3% (6) | 33.3% (24) | 35.0% (20) | 44.4% (27) | 39.5% (38) | 58.3% (12) | |
| Vegan diet failed | 40.0% (55) | 34.8% (66) | 5.7% (70) | 20.0% (15) | 33.3% (6) | 38.1% (21) | 42.1% (19) | 66.7% (18) | 48.0% (25) | 66.7% (9) | |
| AIP diet failed | 40.9% (22) | 41.7% (24) | 14.3% (14) | 7.7% (13) | 20.0% (5) | 40.0% (10) | 50.0% (12) | 25.0% (8) | 20.0% (10) | 60.0% (5) | |
| Wahls protocol failed | 40.0% (5) | 28.6% (7) | 0.0% (4) | 0.0% (4) | 0.0% (4) | 25.0% (4) | 0.0% (2) | 33.3% (3) | 33.3% (3) | 0.0% (1) | |
| Paleo diet failed | 25.0% (12) | 26.3% (19) | 11.1% (18) | 7.1% (14) | 14.3% (7) | 0.0% (3) | 18.2% (11) | 18.2% (11) | 40.0% (10) | 66.7% (3) | |
| Carnivore diet failed | 22.2% (18) | 23.8% (21) | 18.8% (16) | 21.4% (14) | 25.0% (8) | 33.3% (3) | 10.0% (10) | 7.1% (14) | 45.5% (11) | 66.7% (3) | |
| Keto diet failed | 42.4% (33) | 50.0% (36) | 31.8% (22) | 25.0% (8) | 33.3% (9) | 33.3% (3) | 18.2% (11) | 7.1% (14) | 29.4% (17) | 25.0% (4) | |
| Anti inflammatory diet failed | 16.7% (42) | 15.2% (33) | 8.0% (25) | 7.1% (14) | 0.0% (8) | 0.0% (2) | 0.0% (6) | 0.0% (6) | 14.3% (14) | 11.1% (9) | |
| Other diet failed | 16.7% (6) | 40.0% (5) | 16.7% (6) | 25.0% (4) | 0.0% (2) | 0.0% (1) | 0.0% (1) | 0.0% (1) | 0.0% (3) | 0.0% (8) |
These surveyees may be reporting slightly lower recovery (than those who reported negative outcomes from intense exericse). (Results may not necessarily be statistically significant.)
Reported improvement or not much benefit/harm from intense exercise: 117 Exercise responders peak sev: 6.1 Exercise responders curr sev: 3.5 Improvement: 2.5 Reported worsening from exercise: 530 Not exercise responders peak sev 7.1 Not exercise responders curr sev 4.8 Improvement: 2.4
What treatments seemed to work well in the non-responders?
Treatment rankings for ivermectin non-responders
| Treatments with more than 63 data points | Score | Risk score | # of data points (out of 115 surveyees) | |
|---|---|---|---|---|
| 1 | [Meditation] | 0.88 | 0.00 | 68 |
| 2 | [Avoiding exercise] | 0.69 | -0.14 | 78 |
| 3 | [Time] | 0.55 | -0.42 | 110 |
| 4 | [Magnesium] | 0.55 | -0.07 | 104 |
| 5 | [Nattokinase] | 0.44 | -0.08 | 77 |
| 6 | [Aspirin] | 0.34 | -0.04 | 67 |
| 7 | [NAC] | 0.32 | -0.09 | 82 |
| 8 | [Quercetin] | 0.31 | -0.04 | 85 |
| 9 | [Advil] | 0.30 | -0.04 | 67 |
| 10 | [Melatonin] | 0.30 | -0.14 | 79 |
| 11 | [Curcumin] | 0.26 | -0.02 | 84 |
| 12 | [Fish oil etc.] | 0.26 | -0.01 | 78 |
| 13 | [Vitamin D] | 0.25 | -0.12 | 102 |
| 14 | [CoQ10] | 0.20 | -0.01 | 74 |
| 15 | [Probiotics prebiotics] | 0.19 | -0.28 | 75 |
| 16 | [Vitamin C] | 0.18 | -0.06 | 88 |
| 17 | [Zinc] | 0.16 | -0.10 | 83 |
| 18 | [B vitamins] | 0.15 | -0.14 | 95 |
| 19 | [Ivermectin] | -0.30 | -0.30 | 115 |
| 20 | [Tetracyclines, Fluoroquinolones, Penicillins,... | -0.41 | -0.67 | 101 |
| 21 | [Celexa, Lexapro, Fluvoxamine, Prozac, Paxil, ... | -0.68 | -0.89 | 73 |
| 22 | [Light exercise] | -0.94 | -1.17 | 83 |
| 23 | [Intense exercise] | -2.26 | -2.33 | 66 |
Failure is not the same as a non-responder. Worsening/failure is defined as somebody who reported worsening; it does NOT include 'unsure' and 'not much benefit/harm'
Note that the sample sizes are fairly small, so this analysis is likely unreliable.
Data from surveyees who tried both high and low ATA HBOT:
| HBOT <=1.5 ATA | HBOT >1.5 ATA | Difference? | |
|---|---|---|---|
| 1 | Effect unclear | Mild worsening | Effect unclear | Mild worsening |
| 2 | Mild improvement | Mild improvement | |
| 3 | Mild improvement | Mild improvement | |
| 4 | Mild improvement | Significant improvement | Mild improvement | Significant improvement |
| 5 | Mild improvement | Mild improvement | |
| 6 | Mild improvement | Mild improvement | |
| 7 | Mild improvement | Mild improvement | |
| 8 | Mild improvement | Significant improvement | Mild improvement | Significant improvement |
| 9 | Mild improvement | Significant improvement | Mild improvement | Significant improvement |
| 10 | Not much benefit/harm | Mild improvement | Not much benefit/harm | Mild improvement |
| 11 | Not much benefit/harm | Not much benefit/harm | |
| 12 | Not much benefit/harm | Not much benefit/harm | |
| 13 | Not much benefit/harm | Not much benefit/harm | |
| 14 | Not much benefit/harm | Not much benefit/harm | |
| 15 | Not much benefit/harm | Not much benefit/harm | |
| 16 | Significant improvement | Significant improvement | |
| 17 | Significant improvement | Significant improvement | |
| 18 | Significant improvement | Significant improvement | |
| 19 | Significant improvement | Significant improvement | |
| 20 | Significant improvement | Significant improvement |
It seems that those who try only low ATA HBOT tend to rate treatments more favorably than people who try only high ATA HBOT.
This bias might even understate the difference in outcomes between high and low ATA HBOT.
| Treatments with more than 16 data points | Score | Risk score | # of data points (out of 49 surveyees) | |
|---|---|---|---|---|
| 1 | ['Glutenfree diet'] | 1.26 | 0.00 | 19 |
| 2 | ['Low histamine diet'] | 1.23 | 0.00 | 22 |
| 3 | ['Time'] | 1.21 | -0.19 | 43 |
| 4 | ['Pacing strategies'] | 1.21 | 0.00 | 24 |
| 5 | ['HBOT <=1.5 ATA', 'HBOT >1.5 ATA'] | 1.16 | -0.14 | 49 |
| 6 | ['Meditation'] | 1.00 | 0.00 | 21 |
| 7 | ['Aciclovir', 'Famciclovir', 'Valtrex', 'Valcy... | 0.84 | 0.00 | 19 |
| 8 | ['LDN'] | 0.83 | -0.31 | 29 |
| 9 | ['Avoiding exercise'] | 0.83 | -0.14 | 29 |
| 10 | ['Magnesium'] | 0.71 | -0.03 | 38 |
| 11 | ['Zyrtec'] | 0.65 | -0.05 | 20 |
| 12 | ['Water and salt'] | 0.64 | 0.00 | 28 |
| 13 | ['Fish oil etc.'] | 0.56 | 0.00 | 27 |
| 14 | ['Vitamin D'] | 0.55 | -0.05 | 40 |
| 15 | ['Other NSAID'] | 0.53 | -0.06 | 17 |
| 16 | ['Nattokinase'] | 0.52 | -0.14 | 29 |
| 17 | ['Intermittent fasting'] | 0.52 | -0.14 | 21 |
| 18 | ['Aspirin'] | 0.48 | -0.03 | 31 |
| 19 | ['B vitamins'] | 0.48 | -0.05 | 40 |
| 20 | ['Melatonin'] | 0.44 | -0.20 | 25 |
| 21 | ['Compression garments'] | 0.42 | 0.00 | 26 |
| 22 | ['Zinc'] | 0.39 | -0.04 | 28 |
| 23 | ['Claritin'] | 0.36 | -0.05 | 22 |
| 24 | ['Sleeping with head of bed elevated'] | 0.35 | 0.00 | 17 |
| 25 | ['NAC'] | 0.35 | -0.13 | 23 |
| 26 | ['Curcumin'] | 0.30 | -0.03 | 30 |
| 27 | ['Serrapeptase'] | 0.29 | -0.14 | 21 |
| 28 | ['Vitamin C'] | 0.28 | -0.08 | 36 |
| 29 | ['ALA'] | 0.28 | 0.00 | 18 |
| 30 | ['Probiotics prebiotics'] | 0.26 | -0.26 | 31 |
| 31 | ['K vitamins'] | 0.26 | -0.11 | 19 |
| 32 | ['Quercetin'] | 0.24 | -0.04 | 25 |
| 33 | ['Pepcid'] | 0.23 | -0.18 | 22 |
| 34 | ['Glutathione'] | 0.23 | -0.15 | 26 |
| 35 | ['Tetracyclines', 'Fluoroquinolones', 'Penicil... | 0.21 | -0.62 | 34 |
| 36 | ['Acupuncture'] | 0.18 | -0.14 | 22 |
| 37 | ['Advil'] | 0.16 | -0.05 | 19 |
| 38 | ['CoQ10'] | 0.15 | -0.15 | 27 |
| 39 | ['Red light therapy'] | 0.15 | -0.10 | 20 |
| 40 | ['Multivitamin'] | 0.10 | -0.20 | 20 |
| 41 | ['Tylenol'] | 0.06 | -0.06 | 17 |
| 42 | ['Celexa', 'Lexapro', 'Fluvoxamine', 'Prozac',... | 0.03 | -0.55 | 31 |
| 43 | ['Plant based diet', 'Vegan diet'] | -0.29 | -0.82 | 17 |
| 44 | ['Light exercise'] | -0.60 | -1.23 | 30 |
| 45 | ['Intense exercise'] | -2.00 | -2.27 | 26 |
Did those who reported positive outcomes from prayer have roughly the same change in severity as those who did not?
-- Change in severity score (-2 to +10, higher is more recovery) -- Significant improvement from prayer 2.48 Mild improvement from prayer 2.32 Not much improvement or worsening 1.73 Tried prayer 2.15 Did not try prayer 2.41
The chart below plots # of successful treatments on the y-axis and the number of non-successful treatments on the x-axis.
Non-successful includes 'effect unclear' and 'Not much benefit/harm'
A histogram plot of the # of succcessful treatments reported
A histogram plot of the # of non-succcessful treatments reported
Does recovery correlate with successful treatments? Does it correlate with the number of treatments tried?
The chart below plots # of highly successful treatments on the y-axis and the number of other treatments on the x-axis.
The lower number of treatments tried among the lowest (current) severity patients may be partially explained by those patients being less severe (lower peak severity score)...?
| Number of treatments tried | |
|---|---|
| Peak severity score | |
| 3.0 | 28.066667 |
| 4.0 | 25.073171 |
| 5.0 | 27.251908 |
| 6.0 | 29.835749 |
| 7.0 | 30.886207 |
| 8.0 | 30.333333 |
| 9.0 | 35.533074 |
The same histogram, but only of those who mostly recovered
Among those who mostly recovered (87/1173 people), many treatments were rated by some as leading to 'Significant improvement'. Those will be listed in the next section 'All 235 treatments surveyed'
Severity/recovery data was available for 1173 people
Long COVID 690 Vaccine injured 379 ME/CFS 104 Name: Chronic illness, dtype: int64
The mostly recovered consisted of the following chronic illness types:
Long COVID 52 Vaccine injured 30 ME/CFS 5 Name: Chronic illness, dtype: int64
7.92% of vaccine injured with severity data are mostly recovered. 7.54% of Long COVID with severity data are mostly recovered.
29 responses were dropped (at the beginning of all analysis) as their peak severity score was 2 or less. Please note that this skews the data towards lower recovery rates and lower recovery numbers!
The most important column is the third column, which are the people who rated a treatment highly ('significant improvement') AND were mostly recovered. Anything less than ~1.17% may be worse than random.
The second most important column is the first column (Count), which is the total number of successes. If the count is only 1, then the data may not be very reliable due to the small sample sizes involved.
The 2nd and 4th columns indicate the popularity of all the treatments.
| Count | % of surveyees (with recovery data) who tried this | % (of those who tried this) who mostly recovered AND reported significant improvement from this treatment | Number who tried this treatment | |
|---|---|---|---|---|
| Time | 49 | 88.6 | 4.7 | 1039 |
| Vitamin D | 3 | 76.7 | 0.3 | 900 |
| Magnesium | 9 | 71.0 | 1.1 | 833 |
| B vitamins | 5 | 69.3 | 0.6 | 813 |
| Avoiding exercise | 12 | 66.0 | 1.6 | 774 |
| Light exercise | 3 | 65.9 | 0.4 | 773 |
| Vitamin C | 2 | 61.5 | 0.3 | 721 |
| Pacing strategies | 14 | 57.1 | 2.1 | 670 |
| Water and salt | 6 | 55.1 | 0.9 | 646 |
| Meditation | 11 | 54.8 | 1.7 | 643 |
| Probiotics prebiotics | 12 | 52.4 | 2.0 | 615 |
| Intense exercise | 4 | 50.6 | 0.7 | 594 |
| Curcumin | 1 | 50.5 | 0.2 | 592 |
| Fish oil etc. | 3 | 50.1 | 0.5 | 588 |
| Zinc | 3 | 50.0 | 0.5 | 586 |
| Advil | 3 | 49.4 | 0.5 | 579 |
| Melatonin | 2 | 46.2 | 0.4 | 542 |
| CoQ10 | 1 | 46.0 | 0.2 | 539 |
| Quercetin | 1 | 42.8 | 0.2 | 502 |
| Multivitamin | 1 | 42.6 | 0.2 | 500 |
| Tylenol | 0 | 42.6 | 0.0 | 500 |
| NAC | 6 | 41.9 | 1.2 | 491 |
| Aspirin | 4 | 41.7 | 0.8 | 489 |
| Low histamine diet | 8 | 40.5 | 1.7 | 475 |
| Intermittent fasting | 5 | 39.9 | 1.1 | 468 |
| Nattokinase | 10 | 37.9 | 2.3 | 444 |
| Glutenfree diet | 9 | 37.8 | 2.0 | 443 |
| Zyrtec | 6 | 35.0 | 1.5 | 411 |
| Compression garments | 0 | 34.3 | 0.0 | 402 |
| Massage | 2 | 33.0 | 0.5 | 387 |
| CBT | 1 | 32.1 | 0.3 | 376 |
| Drinking water | 3 | 31.3 | 0.8 | 367 |
| Acupuncture | 3 | 31.2 | 0.8 | 366 |
| Pepcid | 1 | 30.9 | 0.3 | 363 |
| Other NSAID | 6 | 28.6 | 1.8 | 335 |
| Beta blockers | 2 | 28.2 | 0.6 | 331 |
| Claritin | 1 | 27.8 | 0.3 | 326 |
| Ashwagandha | 3 | 27.7 | 0.9 | 325 |
| Prayer | 8 | 27.5 | 2.5 | 323 |
| Graded exercise therapy | 3 | 27.4 | 0.9 | 321 |
| LDN | 5 | 27.2 | 1.6 | 319 |
| CBD without THC | 1 | 26.9 | 0.3 | 315 |
| CBD with THC | 0 | 26.3 | 0.0 | 309 |
| VNS | 4 | 26.1 | 1.3 | 306 |
| Sleeping with head of bed elevated | 1 | 25.9 | 0.3 | 304 |
| K vitamins | 1 | 25.5 | 0.3 | 299 |
| Corticosteroids | 5 | 24.3 | 1.8 | 285 |
| Glutathione | 0 | 23.8 | 0.0 | 279 |
| OMAD | 9 | 21.5 | 3.6 | 252 |
| Benzodiazepines | 1 | 21.4 | 0.4 | 251 |
| Count | % of surveyees (with recovery data) who tried this | % (of those who tried this) who mostly recovered AND reported significant improvement from this treatment | Number who tried this treatment | |
|---|---|---|---|---|
| ALA | 0 | 21.3 | 0.0 | 250 |
| Resveratrol | 2 | 20.3 | 0.8 | 238 |
| Plant based diet | 1 | 19.4 | 0.4 | 227 |
| Serrapeptase | 6 | 19.2 | 2.7 | 225 |
| Benadryl | 1 | 19.2 | 0.4 | 225 |
| Ivermectin | 7 | 18.3 | 3.3 | 215 |
| NADH | 0 | 18.0 | 0.0 | 211 |
| Lion's mane | 1 | 17.6 | 0.5 | 207 |
| Gabapentin | 1 | 17.4 | 0.5 | 204 |
| Allegra | 0 | 16.4 | 0.0 | 192 |
| Chiropractic | 1 | 16.1 | 0.5 | 189 |
| Dandelion | 1 | 16.1 | 0.5 | 189 |
| Anti inflammatory diet | 4 | 16.0 | 2.1 | 188 |
| Red light therapy | 2 | 15.9 | 1.1 | 186 |
| 24-48 hour fasting | 3 | 15.6 | 1.6 | 183 |
| Wim Hof with cold | 2 | 14.5 | 1.2 | 170 |
| Augmented NAC | 2 | 14.2 | 1.2 | 167 |
| Other brain retraining | 6 | 13.3 | 3.8 | 156 |
| Infrared sauna | 3 | 13.2 | 1.9 | 155 |
| Lexapro | 1 | 11.9 | 0.7 | 140 |
| Patches | 3 | 11.8 | 2.2 | 138 |
| IV vitamins | 0 | 11.7 | 0.0 | 137 |
| Keto diet | 3 | 11.6 | 2.2 | 136 |
| EMDR | 1 | 11.4 | 0.7 | 134 |
| DAO | 1 | 10.6 | 0.8 | 124 |
| Homeopathy | 0 | 10.4 | 0.0 | 122 |
| Wellbutrin | 0 | 10.4 | 0.0 | 122 |
| Zoloft | 1 | 10.4 | 0.8 | 122 |
| Oil of oregano | 1 | 10.3 | 0.8 | 121 |
| Acrivastine | 0 | 10.1 | 0.0 | 119 |
| Diazepam | 2 | 10.1 | 1.7 | 118 |
| Vegan diet | 0 | 10.1 | 0.0 | 119 |
| Paxlovid | 2 | 9.7 | 1.8 | 114 |
| Other muscle relaxers | 0 | 9.6 | 0.0 | 113 |
| Opiates | 0 | 9.5 | 0.0 | 112 |
| Hydroxyzine | 0 | 9.3 | 0.0 | 109 |
| Traditional sauna | 1 | 9.2 | 0.9 | 108 |
| Multiday wet fasting | 3 | 9.1 | 2.8 | 107 |
| Penicillins | 0 | 9.0 | 0.0 | 105 |
| Statins | 3 | 9.0 | 2.9 | 105 |
| Nigella sativa oil | 2 | 9.0 | 1.9 | 105 |
| Tetracyclines | 1 | 9.0 | 1.0 | 105 |
| Psychedelic mushrooms | 0 | 8.8 | 0.0 | 103 |
| Dry cupping | 0 | 8.7 | 0.0 | 102 |
| Valtrex | 2 | 8.5 | 2.0 | 100 |
| Montelukast | 0 | 8.4 | 0.0 | 98 |
| Osteopathy | 0 | 8.2 | 0.0 | 96 |
| Nigella sativa capsules | 1 | 8.2 | 1.0 | 96 |
| Lavender | 0 | 8.1 | 0.0 | 95 |
| Lumbrokinase | 1 | 8.1 | 1.1 | 95 |
| Count | % of surveyees (with recovery data) who tried this | % (of those who tried this) who mostly recovered AND reported significant improvement from this treatment | Number who tried this treatment | |
|---|---|---|---|---|
| Other TCM | 1 | 7.8 | 1.1 | 92 |
| Seroquel | 0 | 7.8 | 0.0 | 91 |
| Pine needle tea | 0 | 7.7 | 0.0 | 90 |
| Wim Hof without cold | 2 | 7.7 | 2.2 | 90 |
| Activated charcoal | 0 | 7.6 | 0.0 | 89 |
| Other pain relievers | 0 | 7.6 | 0.0 | 89 |
| Vaping | 1 | 7.4 | 1.1 | 87 |
| Carnivore diet | 6 | 7.4 | 6.9 | 87 |
| Cymbalta | 0 | 7.3 | 0.0 | 86 |
| IV vitamin C | 0 | 7.2 | 0.0 | 85 |
| Elavil | 1 | 7.2 | 1.2 | 84 |
| Other diet | 3 | 7.1 | 3.6 | 83 |
| Antiseizure | 0 | 6.8 | 0.0 | 80 |
| Zeolite | 0 | 6.3 | 0.0 | 74 |
| Cigarettes | 0 | 6.3 | 0.0 | 74 |
| Paleo diet | 3 | 6.3 | 4.1 | 74 |
| Plaquenil | 2 | 6.1 | 2.8 | 72 |
| Prozac | 0 | 6.1 | 0.0 | 72 |
| Other nicotine | 1 | 6.0 | 1.4 | 70 |
| Remeron | 0 | 5.7 | 0.0 | 67 |
| Metformin | 0 | 5.7 | 0.0 | 67 |
| HBOT <=1.5 ATA | 0 | 5.7 | 0.0 | 67 |
| HBOT >1.5 ATA | 3 | 5.6 | 4.5 | 66 |
| Monolaurin | 0 | 5.5 | 0.0 | 64 |
| Effexor | 1 | 5.5 | 1.5 | 65 |
| Cat's claw | 2 | 5.4 | 3.2 | 63 |
| Ambien | 0 | 5.3 | 0.0 | 62 |
| AIP diet | 2 | 5.3 | 3.2 | 62 |
| Methylene blue | 2 | 5.2 | 3.3 | 61 |
| Fluconazole | 1 | 4.9 | 1.7 | 58 |
| Other antihistamines | 0 | 4.9 | 0.0 | 58 |
| Bentonite clay | 0 | 4.9 | 0.0 | 58 |
| Doxepin | 1 | 4.9 | 1.8 | 57 |
| Xyzal | 0 | 4.8 | 0.0 | 56 |
| St. John's Wort | 1 | 4.8 | 1.8 | 56 |
| Spermidine | 0 | 4.8 | 0.0 | 56 |
| Ketotifen | 1 | 4.7 | 1.8 | 55 |
| Multiday juice fasting | 1 | 4.6 | 1.9 | 54 |
| Gupta program | 1 | 4.6 | 1.9 | 54 |
| Clopidogrel | 2 | 4.5 | 3.8 | 53 |
| Fluvoxamine | 1 | 4.4 | 1.9 | 52 |
| TRT | 1 | 4.4 | 1.9 | 52 |
| Eliquis | 2 | 4.3 | 4.0 | 50 |
| Guanfacine | 0 | 4.3 | 0.0 | 50 |
| Celexa | 0 | 4.3 | 0.0 | 51 |
| Mestinon | 0 | 4.1 | 0.0 | 48 |
| Colchicine | 2 | 4.1 | 4.2 | 48 |
| Fluoroquinolones | 0 | 3.9 | 0.0 | 46 |
| IV ozone | 0 | 3.9 | 0.0 | 46 |
| Cromolyn | 0 | 3.8 | 0.0 | 45 |
| Count | % of surveyees (with recovery data) who tried this | % (of those who tried this) who mostly recovered AND reported significant improvement from this treatment | Number who tried this treatment | |
|---|---|---|---|---|
| Clarinex | 0 | 3.8 | 0.0 | 44 |
| Abilify | 1 | 3.7 | 2.3 | 43 |
| Macrolides | 0 | 3.5 | 0.0 | 41 |
| Nystatin | 0 | 3.4 | 0.0 | 40 |
| Antibiotic unknown type | 1 | 3.3 | 2.6 | 39 |
| Aciclovir | 2 | 3.3 | 5.1 | 39 |
| Multiday dry fasting | 1 | 3.2 | 2.7 | 37 |
| Pamelor | 1 | 3.1 | 2.8 | 36 |
| Heparin | 1 | 2.8 | 3.0 | 33 |
| Other antibiotic | 0 | 2.7 | 0.0 | 32 |
| DNRS | 0 | 2.7 | 0.0 | 32 |
| Other chelation | 0 | 2.6 | 0.0 | 30 |
| Ayurveda | 0 | 2.5 | 0.0 | 29 |
| Other antifungal | 2 | 2.4 | 7.1 | 28 |
| SGB | 0 | 2.4 | 0.0 | 28 |
| Metronidazole | 0 | 2.2 | 0.0 | 26 |
| NIBS | 0 | 2.2 | 0.0 | 26 |
| Quantum healing | 0 | 2.1 | 0.0 | 25 |
| Maraviroc | 2 | 2.1 | 8.0 | 25 |
| Nigella sativa seed | 0 | 2.0 | 0.0 | 23 |
| Photobiomodulation | 0 | 1.9 | 0.0 | 22 |
| Tollovid | 1 | 1.8 | 4.8 | 21 |
| IVIG | 0 | 1.7 | 0.0 | 20 |
| Vedicinals9 | 0 | 1.7 | 0.0 | 20 |
| Biocidin | 0 | 1.7 | 0.0 | 20 |
| Rife | 0 | 1.7 | 0.0 | 20 |
| Clindamycin | 0 | 1.7 | 0.0 | 20 |
| Monoclonals | 1 | 1.7 | 5.0 | 20 |
| Doxylamine | 0 | 1.6 | 0.0 | 19 |
| Paxil | 0 | 1.6 | 0.0 | 19 |
| Sulfonamides | 0 | 1.5 | 0.0 | 18 |
| Chlorine dioxide | 1 | 1.5 | 5.6 | 18 |
| TWC detox | 0 | 1.4 | 0.0 | 17 |
| Wahls protocol | 0 | 1.4 | 0.0 | 17 |
| EDTA | 0 | 1.4 | 0.0 | 16 |
| Canesten | 0 | 1.4 | 0.0 | 17 |
| Vortioxetine | 1 | 1.3 | 6.7 | 15 |
| Bilastine | 0 | 1.2 | 0.0 | 14 |
| EBOO | 0 | 1.2 | 0.0 | 14 |
| Red yeast rice | 0 | 1.2 | 0.0 | 14 |
| HELP apheresis | 1 | 1.2 | 7.1 | 14 |
| Methotextrate | 0 | 1.2 | 0.0 | 14 |
| Lightning process | 0 | 1.1 | 0.0 | 13 |
| DMARD | 0 | 1.1 | 0.0 | 13 |
| Ketoconazole | 0 | 1.0 | 0.0 | 12 |
| Wet cupping | 0 | 1.0 | 0.0 | 12 |
| Xarelto | 0 | 1.0 | 0.0 | 12 |
| Cephalosporins | 0 | 0.9 | 0.0 | 11 |
| Stem cells | 3 | 0.9 | 30.0 | 10 |
| Frequency wand | 0 | 0.9 | 0.0 | 10 |
| Count | % of surveyees (with recovery data) who tried this | % (of those who tried this) who mostly recovered AND reported significant improvement from this treatment | Number who tried this treatment | |
|---|---|---|---|---|
| Biologic | 0 | 0.9 | 0.0 | 11 |
| Famciclovir | 1 | 0.9 | 9.1 | 11 |
| ASEA Redox | 1 | 0.9 | 9.1 | 11 |
| Root wellness | 1 | 0.9 | 9.1 | 11 |
| Cardio Miracle | 1 | 0.8 | 11.1 | 9 |
| Inuspheresis | 0 | 0.7 | 0.0 | 8 |
| Rupatadine | 0 | 0.7 | 0.0 | 8 |
| Nitrofurantoin | 0 | 0.7 | 0.0 | 8 |
| Rapamycin | 0 | 0.6 | 0.0 | 7 |
| Kangen water | 0 | 0.6 | 0.0 | 7 |
| Molnupiravir | 0 | 0.6 | 0.0 | 7 |
| Alinia | 0 | 0.6 | 0.0 | 7 |
| Immunoadsorption | 0 | 0.5 | 0.0 | 6 |
| Ebastine | 0 | 0.5 | 0.0 | 6 |
| Clomipramine | 0 | 0.5 | 0.0 | 6 |
| SCIG | 0 | 0.4 | 0.0 | 5 |
| Sulodexide | 0 | 0.4 | 0.0 | 5 |
| Semprex D | 0 | 0.3 | 0.0 | 3 |
| Favipiravir | 1 | 0.3 | 33.3 | 3 |
| Urotherapy | 0 | 0.3 | 0.0 | 4 |
| DTPA | 0 | 0.3 | 0.0 | 4 |
| Valcyte | 0 | 0.3 | 0.0 | 3 |
| Miconazole | 0 | 0.3 | 0.0 | 4 |
| HCG | 0 | 0.3 | 0.0 | 3 |
| PLEX | 0 | 0.3 | 0.0 | 4 |
| Terbinafine | 0 | 0.3 | 0.0 | 4 |
| Econazole | 0 | 0.2 | 0.0 | 2 |
| Mizolastine | 0 | 0.2 | 0.0 | 2 |
| Amphotericin | 0 | 0.1 | 0.0 | 1 |
| Aminoglycosides | 0 | 0.1 | 0.0 | 1 |
| Astemizole | 0 | 0.1 | 0.0 | 1 |
| Avacen | 0 | 0.1 | 0.0 | 1 |
| Quifenadine | 0 | 0.1 | 0.0 | 1 |
| Seldane | 0 | 0.1 | 0.0 | 1 |
| Bepotastine | 0 | 0.0 | NaN | 0 |
Click here for the spreadsheet. The spreadsheet will let you conveniently sort and filter the data so that you can get a better picture of how treatments stack up.
If you just want to see the table (without being able to edit it), see here. You will need to change tabs to see the data- look for links at the top or bottom of that page.
Here are the top 60 where no patients became mostly recovered. In other words, these are treatments with the most evidence of ineffectiveness.
1173 people had valid severity data.
| % of surveyees (with recovery data) who tried this | % (of those who tried this) who mostly recovered AND reported significant improvement from this treatment | |
|---|---|---|
| Tylenol | 42.6 | 0.0 |
| Compression garments | 34.3 | 0.0 |
| CBD with THC | 26.3 | 0.0 |
| Glutathione | 23.8 | 0.0 |
| ALA | 21.3 | 0.0 |
| NADH | 18.0 | 0.0 |
| Allegra | 16.4 | 0.0 |
| IV vitamins | 11.7 | 0.0 |
| Homeopathy | 10.4 | 0.0 |
| Wellbutrin | 10.4 | 0.0 |
| Vegan diet | 10.1 | 0.0 |
| Acrivastine | 10.1 | 0.0 |
| Other muscle relaxers | 9.6 | 0.0 |
| Opiates | 9.5 | 0.0 |
| Hydroxyzine | 9.3 | 0.0 |
| Penicillins | 9.0 | 0.0 |
| Psychedelic mushrooms | 8.8 | 0.0 |
| Dry cupping | 8.7 | 0.0 |
| Montelukast | 8.4 | 0.0 |
| Osteopathy | 8.2 | 0.0 |
| Lavender | 8.1 | 0.0 |
| Seroquel | 7.8 | 0.0 |
| Pine needle tea | 7.7 | 0.0 |
| Activated charcoal | 7.6 | 0.0 |
| Other pain relievers | 7.6 | 0.0 |
| Cymbalta | 7.3 | 0.0 |
| IV vitamin C | 7.2 | 0.0 |
| Antiseizure | 6.8 | 0.0 |
| Cigarettes | 6.3 | 0.0 |
| Zeolite | 6.3 | 0.0 |
| Prozac | 6.1 | 0.0 |
| HBOT <=1.5 ATA | 5.7 | 0.0 |
| Remeron | 5.7 | 0.0 |
| Metformin | 5.7 | 0.0 |
| Monolaurin | 5.5 | 0.0 |
| Ambien | 5.3 | 0.0 |
| Bentonite clay | 4.9 | 0.0 |
| Other antihistamines | 4.9 | 0.0 |
| Spermidine | 4.8 | 0.0 |
| Xyzal | 4.8 | 0.0 |
| Celexa | 4.3 | 0.0 |
| Guanfacine | 4.3 | 0.0 |
| Mestinon | 4.1 | 0.0 |
| IV ozone | 3.9 | 0.0 |
| Fluoroquinolones | 3.9 | 0.0 |
| Clarinex | 3.8 | 0.0 |
| Cromolyn | 3.8 | 0.0 |
| Macrolides | 3.5 | 0.0 |
| Nystatin | 3.4 | 0.0 |
| Other antibiotic | 2.7 | 0.0 |
| DNRS | 2.7 | 0.0 |
| Other chelation | 2.6 | 0.0 |
| Ayurveda | 2.5 | 0.0 |
| SGB | 2.4 | 0.0 |
| Metronidazole | 2.2 | 0.0 |
| NIBS | 2.2 | 0.0 |
| Quantum healing | 2.1 | 0.0 |
| Nigella sativa seed | 2.0 | 0.0 |
| Photobiomodulation | 1.9 | 0.0 |
| Clindamycin | 1.7 | 0.0 |
'Realists'/'pessimists' are defined as people who reported more than 2 non-successful treatments for every successful treatment.
Number of realists/pessimists: 377 All surveyees: 1337 Rankings from realists are shown below:
Hierarchical clustering was used to try to find potential phenotypes of chronic illness. In this situation, it is unlikely that the analysis found a distinct phenotype. In my experience, hierarchical clustering usually spots surveyees who have a different style when answering surveys. Those phenomena tend to drown out any subtle phenotypes, if they exist.
Of 1337 data points, 1137 had valid severity data that could be used for the cluster analysis
The diagram below is a dendrogram. DisplayR.com has an excellent webpage on how to read dendrograms. Visit https://www.displayr.com/what-is-dendrogram/ or https://archive.ph/4PN2f
Symptoms were rated on a subjective scale. -1 = don't have this symptoms. 0 = no suffering. 4 = worst suffering imaginable. Avoidance behaviours (for light/sound sensitivity) are on a scale of 0 to 1, or 0% to 100%. e.g. 44% wore sunglasses indoors.
Number of people in each cluster
0.0 395 1.0 276 2.0 303 3.0 163 Name: Cluster, dtype: int64
| Cluster | 0.0 | 1.0 | 2.0 | 3.0 |
|---|---|---|---|---|
| Employment severity peak | 2.501272 | 2.154412 | 2.375415 | 2.734568 |
| Employment severity current | 2.058511 | 1.385768 | 1.456081 | 2.421053 |
| Peak pain | 2.364557 | 0.721014 | 1.620462 | 3.171779 |
| Peak depression | 2.225316 | 1.340580 | 1.465347 | 2.791411 |
| Peak cognitive difficulties | 3.086076 | 1.847826 | 2.399340 | 3.411043 |
| Peak sleep issues | 2.592405 | 1.568841 | 2.132013 | 3.263804 |
| Peak bleeding disorders | -0.597468 | -0.873188 | -0.330033 | 0.398773 |
| Peak clotting disorders | -0.374684 | -0.655797 | 0.168317 | 0.619632 |
| Peak POTS OI | 2.192405 | 0.648551 | 1.749175 | 3.380368 |
| Peak food intolerances | 1.797468 | -0.369565 | 1.980198 | 2.312883 |
| Peak sound sensitivity | 2.334177 | 0.394928 | 1.442244 | 3.251534 |
| Peak light sensitivity | 2.296203 | 0.260870 | 1.085809 | 3.122699 |
| Peak other symptoms | 2.600000 | 1.057971 | 2.541254 | 3.460123 |
| Current pain | 1.498734 | 0.039855 | 0.471947 | 2.564417 |
| Current depression | 1.301266 | 0.503623 | 0.343234 | 2.226994 |
| Current cognitive difficulties | 2.068354 | 0.822464 | 0.854785 | 2.717791 |
| Current sleep issues | 1.640506 | 0.648551 | 0.567657 | 2.656442 |
| Current bleeding disorders | -0.718987 | -0.880435 | -0.617162 | 0.202454 |
| Current clotting disorders | -0.556962 | -0.753623 | -0.320132 | 0.288344 |
| Current POTS OI | 1.248101 | -0.036232 | 0.386139 | 2.466258 |
| Current food intolerances | 1.088608 | -0.539855 | 0.914191 | 1.834356 |
| Current sound sensitivity | 1.377215 | -0.206522 | 0.069307 | 2.331288 |
| Current light sensitivity | 1.281013 | -0.376812 | -0.039604 | 2.239264 |
| Current other symptoms | 1.830380 | 0.384058 | 1.151815 | 2.846626 |
| Age | 40.570332 | 43.237226 | 42.243333 | 41.425926 |
| Sunglasses | 0.320611 | 0.109890 | 0.153846 | 0.472393 |
| Avoided outdoors | 0.519084 | 0.157509 | 0.267559 | 0.650307 |
| Avoided bright environments | 0.699746 | 0.267399 | 0.458194 | 0.852761 |
| No light sensitivity | 0.216285 | 0.659341 | 0.478261 | 0.092025 |
| Earpro | 0.503797 | 0.202206 | 0.335548 | 0.705521 |
| Avoided loud environments | 0.774684 | 0.363971 | 0.601329 | 0.883436 |
| No sound sensitivity | 0.146835 | 0.584559 | 0.332226 | 0.061350 |
One way to describe the clusters would be:
Survey questions were:
"Have you done any of the following due to sensitivity to light?"
"Have you done any of the following due to sensitivity to sound?"
The two high-severity clusters had roughly the same percentage answering the objective questions about avoidance behaviours. However, one of those clusters rated their subjective suffering slightly higher (on average).
If Long COVID, ME/CFS, and vaccine injury have differences then one might expect the cluster analysis to reflect that.
Suppose that cluster 3 has an unusually high proportion of vaccine injured individuals. My opinion is that the cluster reflect surveyees who answer surveys with a particular style rather than underlying medical differences.
Aside from that cluster, the postvax and Long COVID patients are hard to distinguish based on the survey questions asked. However, this survey was not designed to find differences. (There are other surveys with better data on this issue.) There was no survey question about loss of smell or taste- a symptom that may be far more common in Long COVID.
Cluster 0
Long COVID 231 Vaccine injured 129 ME/CFS 35 Name: Chronic illness, dtype: int64
Cluster 1
Long COVID 171 Vaccine injured 81 ME/CFS 24 Name: Chronic illness, dtype: int64
Cluster 2
Long COVID 184 Vaccine injured 94 ME/CFS 25 Name: Chronic illness, dtype: int64
Cluster 3
Long COVID 83 Vaccine injured 68 ME/CFS 12 Name: Chronic illness, dtype: int64
This analysis looks at symptoms that are similar to each other than than people who are similar to each other.
I was curious to see if light and sound sensitivity were 2 symptoms characteristic of its own phenotype, as an underyling medical cause (e.g. meningitis) would lead to a distinct phenotype. Perhaps a survey or study designed to look for phenotypes would be able to find distinct phenotypes.
The bleeding and clotting disorders form the most distinct cluster (4, 5, 15, 16 in the dendrogram above). This likely reflects how those surveyees answered the survey as they typically reported BOTH bleeding and too much clotting. It may not reflect underlying medical differences.
Of 24 patients who reported 1 or higher for subjective suffering from clotting disorders, only 2 reported taking a prescription drug thinner (clopidogrel or clopidogrel + heparin). 10 did not try any of the natural anticoag supplements (serra, natto, lumbro).
Symptom followed by which cluster they are grouped into
Peak pain 0 Peak depression 0 Peak cognitive difficulties 0 Peak sleep issues 0 Peak bleeding disorders 1 Peak clotting disorders 1 Peak POTS OI 2 Peak food intolerances 2 Peak sound sensitivity 2 Peak light sensitivity 2 Peak other symptoms 0 Current pain 0 Current depression 0 Current cognitive difficulties 2 Current sleep issues 2 Current bleeding disorders 1 Current clotting disorders 1 Current POTS OI 2 Current food intolerances 2 Current sound sensitivity 2 Current light sensitivity 2 Current other symptoms 0 Name: Cluster, dtype: int64
Treatments sorted from most data points (people who reported data for the treatment) to least. The top 60 are shown. See earlier tables (All 235 treatments surveyed) for a complete list.
| Treatments with more than 0 data points | Score | Risk score | # of data points (out of 1337 surveyees) | Percentage tried (%) | |
|---|---|---|---|---|---|
| 1 | [Time] | 0.90 | -0.30 | 1172 | 87.7 |
| 2 | [Vitamin D] | 0.49 | -0.04 | 1009 | 75.5 |
| 3 | [Magnesium] | 0.75 | -0.06 | 935 | 69.9 |
| 4 | [B vitamins] | 0.51 | -0.07 | 911 | 68.1 |
| 5 | [Avoiding exercise] | 0.97 | -0.15 | 853 | 63.8 |
| 6 | [Light exercise] | -0.52 | -0.98 | 848 | 63.4 |
| 7 | [Vitamin C] | 0.42 | -0.04 | 805 | 60.2 |
| 8 | [Pacing strategies] | 1.40 | -0.04 | 734 | 54.9 |
| 9 | [Water and salt] | 1.02 | -0.02 | 723 | 54.1 |
| 10 | [Meditation] | 1.05 | -0.02 | 708 | 53.0 |
| 11 | [Probiotics prebiotics] | 0.59 | -0.10 | 682 | 51.0 |
| 12 | [Curcumin] | 0.46 | -0.05 | 666 | 49.8 |
| 13 | [Zinc] | 0.43 | -0.03 | 660 | 49.4 |
| 14 | [Fish oil etc.] | 0.43 | -0.03 | 658 | 49.2 |
| 15 | [Intense exercise] | -2.04 | -2.24 | 647 | 48.4 |
| 16 | [Advil] | 0.36 | -0.13 | 639 | 47.8 |
| 17 | [CoQ10] | 0.43 | -0.05 | 608 | 45.5 |
| 18 | [Melatonin] | 0.50 | -0.17 | 602 | 45.0 |
| 19 | [Quercetin] | 0.52 | -0.06 | 570 | 42.6 |
| 20 | [Multivitamin] | 0.31 | -0.06 | 567 | 42.4 |
| 21 | [Tylenol] | 0.31 | -0.06 | 560 | 41.9 |
| 22 | [NAC] | 0.52 | -0.10 | 551 | 41.2 |
| 23 | [Aspirin] | 0.39 | -0.10 | 545 | 40.8 |
| 24 | [Intermittent fasting] | 0.62 | -0.14 | 518 | 38.7 |
| 25 | [Low histamine diet] | 1.29 | -0.00 | 516 | 38.6 |
| 26 | [Nattokinase] | 0.58 | -0.14 | 505 | 37.8 |
| 27 | [Glutenfree diet] | 1.21 | -0.01 | 492 | 36.8 |
| 28 | [Zyrtec] | 0.65 | -0.11 | 446 | 33.4 |
| 29 | [Compression garments] | 0.73 | -0.05 | 438 | 32.8 |
| 30 | [Massage] | 0.63 | -0.17 | 428 | 32.0 |
| 31 | [Drinking water] | 0.87 | -0.00 | 411 | 30.7 |
| 32 | [CBT] | 0.53 | -0.13 | 405 | 30.3 |
| 33 | [Acupuncture] | 0.60 | -0.18 | 401 | 30.0 |
| 34 | [Pepcid] | 0.58 | -0.20 | 397 | 29.7 |
| 35 | [Other NSAID] | 0.35 | -0.20 | 377 | 28.2 |
| 36 | [Beta blockers] | 0.69 | -0.34 | 369 | 27.6 |
| 37 | [Prayer] | 1.20 | -0.02 | 368 | 27.5 |
| 38 | [LDN] | 0.69 | -0.33 | 357 | 26.7 |
| 39 | [Ashwagandha] | 0.29 | -0.19 | 356 | 26.6 |
| 40 | [Claritin] | 0.55 | -0.12 | 356 | 26.6 |
| 41 | [CBD with THC] | 0.39 | -0.40 | 348 | 26.0 |
| 42 | [CBD without THC] | 0.39 | -0.15 | 346 | 25.9 |
| 43 | [K vitamins] | 0.36 | -0.06 | 341 | 25.5 |
| 44 | [Sleeping with head of bed elevated] | 0.53 | -0.08 | 336 | 25.1 |
| 45 | [Graded exercise therapy] | -0.69 | -1.18 | 335 | 25.1 |
| 46 | [VNS] | 0.85 | -0.07 | 332 | 24.8 |
| 47 | [Corticosteroids] | 0.48 | -0.46 | 328 | 24.5 |
| 48 | [Glutathione] | 0.46 | -0.09 | 315 | 23.6 |
| 49 | [Benzodiazepines] | 1.06 | -0.17 | 303 | 22.7 |
| 50 | [ALA] | 0.45 | -0.06 | 278 | 20.8 |
| 51 | [OMAD] | 0.43 | -0.32 | 276 | 20.6 |
| 52 | [Resveratrol] | 0.44 | -0.04 | 266 | 19.9 |
| 53 | [Plant based diet] | 0.65 | -0.14 | 257 | 19.2 |
| 54 | [Serrapeptase] | 0.65 | -0.08 | 249 | 18.6 |
| 55 | [Benadryl] | 0.35 | -0.20 | 246 | 18.4 |
| 56 | [Ivermectin] | 0.91 | -0.14 | 245 | 18.3 |
| 57 | [Lion's mane] | 0.36 | -0.13 | 241 | 18.0 |
| 58 | [Gabapentin] | 0.06 | -0.53 | 234 | 17.5 |
| 59 | [NADH] | 0.40 | -0.12 | 230 | 17.2 |
| 60 | [Allegra] | 0.57 | -0.10 | 218 | 16.3 |
Treatments sorted from highest risk score to lowest risk score. May be limited to the 60 riskiest treatments.
| Treatments with more than 228 data points | Score | Risk score | # of data points (out of 1337 surveyees) | |
|---|---|---|---|---|
| 1 | [Intense exercise] | -2.04 | -2.24 | 647 |
| 2 | [Graded exercise therapy] | -0.69 | -1.18 | 335 |
| 3 | [Light exercise] | -0.52 | -0.98 | 848 |
| 4 | [Celexa, Lexapro, Fluvoxamine, Prozac, Paxil, ... | -0.30 | -0.74 | 553 |
| 5 | [Remeron, Seroquel, Wellbutrin] | -0.25 | -0.68 | 316 |
| 6 | [Tetracyclines, Fluoroquinolones, Penicillins,... | 0.02 | -0.54 | 524 |
| 7 | [Gabapentin] | 0.06 | -0.53 | 234 |
| 8 | [Corticosteroids] | 0.48 | -0.46 | 328 |
| 9 | [CBD with THC] | 0.39 | -0.40 | 348 |
| 10 | [Beta blockers] | 0.69 | -0.34 | 369 |
| 11 | [LDN] | 0.69 | -0.33 | 357 |
| 12 | [OMAD] | 0.43 | -0.32 | 276 |
| 13 | [Time] | 0.90 | -0.30 | 1172 |
| 14 | [Plant based diet, Vegan diet] | 0.55 | -0.21 | 386 |
| 15 | [Benadryl] | 0.35 | -0.20 | 246 |
| 16 | [Other NSAID] | 0.35 | -0.20 | 377 |
| 17 | [Pepcid] | 0.58 | -0.20 | 397 |
| 18 | [Ashwagandha] | 0.29 | -0.19 | 356 |
| 19 | [Acupuncture] | 0.60 | -0.18 | 401 |
| 20 | [Benzodiazepines] | 1.06 | -0.17 | 303 |
| 21 | [Melatonin] | 0.50 | -0.17 | 602 |
| 22 | [Avoiding exercise] | 0.97 | -0.15 | 853 |
| 23 | [CBD without THC] | 0.39 | -0.15 | 346 |
| 24 | [Nattokinase] | 0.58 | -0.14 | 505 |
| 25 | [Ivermectin] | 0.91 | -0.14 | 245 |
| 26 | [Intermittent fasting] | 0.62 | -0.14 | 518 |
| 27 | [CBT] | 0.53 | -0.13 | 405 |
| 28 | [Advil] | 0.36 | -0.13 | 639 |
| 29 | [Lion's mane] | 0.36 | -0.13 | 241 |
| 30 | [NADH] | 0.40 | -0.12 | 230 |
| 31 | [Claritin] | 0.55 | -0.12 | 356 |
| 32 | [Zyrtec] | 0.65 | -0.11 | 446 |
| 33 | [NAC] | 0.52 | -0.10 | 551 |
| 34 | [Probiotics prebiotics] | 0.59 | -0.10 | 682 |
| 35 | [Aspirin] | 0.39 | -0.10 | 545 |
| 36 | [Glutathione] | 0.46 | -0.09 | 315 |
| 37 | [Serrapeptase] | 0.65 | -0.08 | 249 |
| 38 | [Sleeping with head of bed elevated] | 0.53 | -0.08 | 336 |
| 39 | [VNS] | 0.85 | -0.07 | 332 |
| 40 | [B vitamins] | 0.51 | -0.07 | 911 |
| 41 | [Tylenol] | 0.31 | -0.06 | 560 |
| 42 | [K vitamins] | 0.36 | -0.06 | 341 |
| 43 | [Magnesium] | 0.75 | -0.06 | 935 |
| 44 | [ALA] | 0.45 | -0.06 | 278 |
| 45 | [Quercetin] | 0.52 | -0.06 | 570 |
| 46 | [Multivitamin] | 0.31 | -0.06 | 567 |
| 47 | [Compression garments] | 0.73 | -0.05 | 438 |
| 48 | [CoQ10] | 0.43 | -0.05 | 608 |
| 49 | [Curcumin] | 0.46 | -0.05 | 666 |
| 50 | [Pacing strategies] | 1.40 | -0.04 | 734 |
| 51 | [Vitamin D] | 0.49 | -0.04 | 1009 |
| 52 | [Resveratrol] | 0.44 | -0.04 | 266 |
| 53 | [Vitamin C] | 0.42 | -0.04 | 805 |
| 54 | [Fish oil etc.] | 0.43 | -0.03 | 658 |
| 55 | [Zinc] | 0.43 | -0.03 | 660 |
| 56 | [Water and salt] | 1.02 | -0.02 | 723 |
| 57 | [Meditation] | 1.05 | -0.02 | 708 |
| 58 | [Prayer] | 1.20 | -0.02 | 368 |
| 59 | [Glutenfree diet] | 1.21 | -0.01 | 492 |
| 60 | [Low histamine diet] | 1.29 | -0.00 | 516 |
The survey asked "What was the one treatment (or combination of treatments) that helped you the most?". I manually analyzed the answers of those who were mostly recovered. There is some subjectivity involved in that analysis.
I categorized treatments into groups (e.g. pacing strategies) so that they could be counted.
Some patients reported that multiple treatments helped the most. That is why the total count is much higher than the number of people who were mostly recovered.
For the defintion of 'mostly recovered', see the earlier section "Heatmap of severity during worst month versus severity during past 30 days".
| Name of treatment(s) that helped the most | Count |
|---|---|
| Fasting | 12 |
| No answer | 10 |
| Exercise | 9 |
| Time | 9 |
| Magnesium | 6 |
| NAC | 6 |
| Pacing strategies | 6 |
| Ivermectin | 5 |
| Meditation | 5 |
| Nattokinase | 4 |
| Rest | 4 |
| Diet | 3 |
| LDN | 3 |
| Maraviroc | 3 |
| Nicotine | 3 |
| Amitriptyline | 2 |
| Being outdoors more | 2 |
| Beta blocker | 2 |
| Black seed oil | 2 |
| Brain retraining | 2 |
| Brain retraining - Sarno | 2 |
| Bromelain | 2 |
| Diet- carnivore diet | 2 |
| Diet- clean diet | 2 |
| Diet- low histamine | 2 |
| Electrolytes | 2 |
| HBOT | 2 |
| No treatment helped | 2 |
| Statin | 2 |
| Stem cells | 2 |
| Triple anticoag | 2 |
| Vitamin D | 2 |
| Acceptance | 1 |
| Aciclovir | 1 |
| Advil | 1 |
| Angiotensin receptor blocking drugs (ARBs) | 1 |
| Anti-inflammatory diet | 1 |
| Anti-inflammatory meds | 1 |
| Antibiotics | 1 |
| Antidepressants | 1 |
| Antivirals | 1 |
| Aripiprazole (Abilify) | 1 |
| ASEA Redox | 1 |
| Ashwagandha | 1 |
| Avoiding alcohol and caffeine | 1 |
| Avoiding caffeine | 1 |
| Cardio Miracle | 1 |
| Cetirizine | 1 |
| Chlorella | 1 |
| Chlorine dioxide | 1 |
| Cleaning gut [Food and Cleaning Gut] | 1 |
| Cold plunges | 1 |
| Colostrum | 1 |
| Compression garments | 1 |
| Copper | 1 |
| Corticosteroids | 1 |
| Curcumin | 1 |
| Custom liquid herbal tinctures/supplements | 1 |
| De-stress | 1 |
| Diet- Low carb | 1 |
| Diet- low sugar | 1 |
| Elimination diet | 1 |
| Fluvoxamine | 1 |
| Getting COVID | 1 |
| Graded exposure therapy | 1 |
| Guaifenesin | 1 |
| Gut health supplements | 1 |
| HELP apheresis | 1 |
| High dose folic acid | 1 |
| Honey | 1 |
| Improving social relationships | 1 |
| Internal Family Systems psychotherapy | 1 |
| Itraconazole | 1 |
| Low processed food | 1 |
| Lysine | 1 |
| Massage therapy | 1 |
| Mebendazole | 1 |
| Melatonin | 1 |
| Methylene blue | 1 |
| Midodrine | 1 |
| Monoclonal antibodies | 1 |
| Neurolinguistic Programming | 1 |
| NSAID | 1 |
| Omega 3:6 ratio diet. | 1 |
| Optimism | 1 |
| Ovine Thymus extract | 1 |
| Paleo/keto diet | 1 |
| Paxlovid | 1 |
| Physical therapy | 1 |
| Plaquenil | 1 |
| Prayer | 1 |
| Prebiotics and Probiotics | 1 |
| Prebiotics and/or probiotics | 1 |
| Probiotics | 1 |
| Pycnogenol | 1 |
| Raw camel milk | 1 |
| Resveratrol | 1 |
| Sauna | 1 |
| Serrapeptase | 1 |
| Somatic Experiencing and touch work | 1 |
| Somatic therapy | 1 |
| Sunlight | 1 |
| Supplements (unspecified) | 1 |
| Trazodone | 1 |
| Valtrex | 1 |
| Vision rehab therapy | 1 |
| Vitamin B1 | 1 |
| Wim Hof | 1 |
| Yogic breathing | 1 |
| Zyrtec | 1 |
The survey asked "What was the one treatment (or combination of treatments) that helped you the most?". The answers of the mostly recovered have been paraphrased to reduce the length of long answers. My comments are in [brackets] to provide additional detail on the treatment mentioned.
| Chronic illness | Paraphrased answer to "What was the one treatment (or combination of treatments) that helped you the most? |
|---|---|
| Long COVID | Rest |
| Long COVID | No answer |
| Long COVID | 18 day water only fast |
| Long COVID | Consistent gentle exercise and supplements. |
| Long COVID | Hope Biosciences stem cells + vision rehab therapy (concussion protocol) |
| Long COVID | Time |
| Long COVID | No answer |
| Long COVID | Antivirals and antiinflammatory meds |
| Long COVID | Somatic Experiencing, somatic touch work, Electrolytes |
| Long COVID | magnesium, black seed oil |
| Long COVID | No answer |
| Long COVID | Exercise and time |
| Long COVID | HBOT, LDN, physical therapy |
| Long COVID | No answer |
| Long COVID | Time |
| Long COVID | Triple anti-coagulant therapy, HELP apheresis |
| Long COVID | Magnesium glycinate |
| Long COVID | Time. Avoid alcohol and caffeine. Eat low carb. Light excercise. Advil for flare ups. My long lasting condition is pericarditis. |
| Long COVID | Time, fasting, ivermectin, black seed oil, honey, probiotics, vitamin D, copper, raw camel milk, colostrum, light exercise, massage therapy, magnesium, sunlight, de-stress, antiinflammatory diet |
| Long COVID | No treatment helped |
| Long COVID | Low sugar, low processed food, intermittent fasting, slow pacing with walking/running |
| Long COVID | Anti histamine diet to lower inflammation - cold plunges to calm down the nervous system |
| Long COVID | methylprednisolone taper then aripiprazole (Abilify); maraviroc + statin; triple anti-coagulant therapy |
| Long COVID | NAC |
| Long COVID | Time and rest |
| Long COVID | Fluvoxamine + trazodone + 2.5mg melatonin insomnia (worst symptom) |
| Long COVID | Bisoprolol [beta blocker] |
| Long COVID | Time |
| Long COVID | 1th=Mebendazole!! 2th=Pycnogenol [Mebendazole is an antiparasitic drug; Pycnogenol is a trademarked maritime pine bark extract] |
| Long COVID | Meditation, Ashwagandha, magnesium, amitriptyline (for sleep) propranolol (for high heart rate - clean diet full of fruit and veg) |
| Long COVID | Shotgun Elimination Diet(no processed food, no acidic food, no histamine food, lower amount of carbs, very little fibre most vegetables are cooked a lot)+(intermittent) fasting + de-stressing nervous system using meditation, wim hof, yogic breathing and prayer |
| Long COVID | sauna [infrared and traditional], slowly increasing activity without getting to the point of over exertion. |
| Long COVID | TMS [John Sarno's TMS program] |
| Long COVID | Ovine Thymus extract |
| Long COVID | Resting, pacing, and gratitude/optimism. |
| Long COVID | When I started LDN and Valtrex around the same time, I began to see more improvement in overall pain and feelings of wellness. |
| Long COVID | Lysine and Aciclovir. Also self injecting b12 took me up a level but it was the antivirals that helped me the most. |
| Long COVID | [Diet with increased omega 3:6 ratio. Clean diet, no refined carbs, lean meat, grains, fermented foods. NAC+, nattokinase, Bromelain, Curcumin, vitamin d, magnesium, pre and probiotics, nicotine gum, exercise. Cetirizine.] |
| Long COVID | No answer |
| Long COVID | zyrtec brought relief within 10mins. recovery began after full 10day course of ivermectin. still take zyrtec occasionally for mild lingering symptoms after 2 years |
| Long COVID | Nicotine patches, a long fast while on 2 strong antibiotics for diverticulitis, brain-training mixed with pacing, getting out in nature, and movement without doing too much |
| Long COVID | Internal Family Systems + Neurolinguistic Programming + Dr Sarno's Mindbody Prescription (permanent cumulative improvement; everything else was temporary) |
| Long COVID | Pacing, being more in the sun and fasting OMAD |
| Long COVID | Graded exposure therapy, acceptance, meditation |
| Long COVID | Plaquenil and Mobic [Meloxicam, a NSAID] brought me out of the pain, and the rest followed. |
| Long COVID | No answer |
| Long COVID | No answer |
| Long COVID | High dose folic acid (20mg per day for up to 4 months) with b complex vitamins as co-factors. [...] |
| Long COVID | antidepressants and avoid caffeine |
| Long COVID | stopping exercise, (which was walking for me) if heart rate exceeded 80% of max heart rate increasing length of walk ridiculously slowly, one day rest between walk days [Note: this participant rated pacing strategies as significant improvement] |
| Long COVID | meditation, intense pacing, betablocker [Note: this participant rated pacing strategies as significant improvement] |
| Long COVID | Improving social relationships |
| ME/CFS | No answer |
| ME/CFS | Antihistaminicum NAC [Antihistaminicum is the Dutch word for antihistamine] |
| ME/CFS | Itraconazole [antifungal drug] |
| ME/CFS | Electrolytes, protein, fluid, non sleep deep rest, never ever crash, move/stretch every day where possible, compression socks, midon [midodrine], Amitriptyline. |
| ME/CFS | [ Diet (LOW carbohydrate, high protein, very high fibre [4-6 cups veg a day], no sugar, gluten, dairy, caffeine or alcohol), Gut health supplementation, Lowering my stress levels holistically (meditation, lifestyle + relationship changes), TRE trauma + release therapy (somatic therapy), Brain retraining (The Switch) ] |
| Vaccine injured | Ivermectin |
| Vaccine injured | Fasting in combination with a well sourced (local farm) carnivore diet. |
| Vaccine injured | Rest, custom liquid herbal tinctures/supplements and low histamine diet. |
| Vaccine injured | Nicotine, [Augmented/Quantum] NAC and fasting |
| Vaccine injured | NAC and Bromelain together |
| Vaccine injured | Chlorella [*Type of algae that grows in fresh water.] |
| Vaccine injured | Ivermectin, NAC, nattokinase, cardio miracle |
| Vaccine injured | No treatment |
| Vaccine injured | [ ASEA Redox ] At the end of October my mom discovered ASEA Redox and by Christmas I was SO MUCH BETTER!!! |
| Vaccine injured | Getting covid for the first time (year after vaccine doses) |
| Vaccine injured | [ Maraviroc, Statin and Plavix / clopidogrel resolved extremely debilitating brain inflammation ] |
| Vaccine injured | Guaifenesin [OTC cough medicine], nattokinase, Resveratrol |
| Vaccine injured | Vitamin b1 |
| Vaccine injured | Nattokinase and Serrapeptase |
| Vaccine injured | Aviv HBoT 3-month protocol. [*Aviv likely refers to aviv-clinics.com; high pressure HBOT] |
| Vaccine injured | LDN, methylene blue and chlorine dioxide. |
| Vaccine injured | Fasting |
| Vaccine injured | Dry fasting 72 hrs |
| Vaccine injured | Paleo/keto diet. |
| Vaccine injured | Time and fasting (1 meal a day or eating less) |
| Vaccine injured | Time |
| Vaccine injured | A combination of diet modifications, intermittent fasting and introducing of Gut Shot, Kifer [Kefir?], prebiotic (wildbrine) completely improved my digestive system. |
| Vaccine injured | Dr Pattersons protocol [*Note: this person did not report results for statins or maraviroc in the survey questions, stated that maraviroc helped them in the freeform question about treatments not surveyed; stated not much benefit for ivermectin; it is unclear what their protocol was; ] |
| Vaccine injured | Rest |
| Vaccine injured | Stem cell therapy, 10 days of pax after a Re infection [Paxlovid], mabs at my worst [monoclonal antibodies]. Just believe I needed more mabs. |
| Vaccine injured | No answer |
| Vaccine injured | Food and Cleaning Gut. |
| Vaccine injured | ARBs (candesartan, olmesartan) + magnesium |
| Vaccine injured | Ivermectin |
| Vaccine injured | Carnivore diet |
Please visit https://forum.sickandabandoned.com/t/what-treatments-helped-the-most-some-prelim-patient-experiences-survey-data/351 for that analysis with some commentary.
Questions? Please email glennchan /at/ gmail [dot] com
Please visit the Sick and Abandoned.com website's research section - https://sickandabandoned.com/pes-slides/ - to find publications / analyses of this data. Thank you.